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C. trachomatis is an obligate intracellular pathogen that is a leading cause o f  sexually 
transmitted diseases and blinding trachoma worldwide. Genes encoded in the plasticity 
zone (PZ) and the polymorphic membrane proteins (Pmps) represent major virulence 
determinants for chlamydiae. Elucidating their roles will be essential for the 
development o f a vaccine to control human chlamydial diseases.
The PZ MACPF domain protein CT153 is expressed as a 91 kDa polypeptide in 
elementary bodies o f  all human serovariants suggesting a common function. CT153 is 
processed during infection into an N-terminal p42 and a C-terminal p59 that contains the 
MACPF domain. Similar processing was observed following heterologous expression 
suggesting autocatalytic proteolysis. Immunoelectron microscopy revealed that CT153 
shared localization patterns with Hsp60 and CT155, a PZ phospholipase D (PLD) 
paralog. CT153 stained reticulate bodies (RBs) adjacent to the inclusion membrane and 
morphologically atypical RBs that tended to associate with inclusion-sequestered lipid 
droplets. Collectively, these results suggest CT153 and the PZ PLDs share a concomitant 
function within a subpopulation o f RBs involving lipid metabolism or acquisition.
PmpD is a vaccine candidate as it is highly conserved and is a target o f  cross-reactive 
neutralizing antibodies. Immunoaffinity-purified native PmpD exists as an oligomer with 
a 23 nm flower-like structure. Two-dimensional blue native/SDS-PAGE analyses 
showed oligomers were comprised o f full length PmpD and two processed fragments: 
p73 passenger domain (PD) and p82 translocator domain. PmpD undergoes infection- 
dependent proteolysis late during the developmental cycle that yields a soluble extended 
PD (pi 11) that was processed into a p73 PD and a novel p30 fragment. Soluble PmpD 
peptides possess putative eukaryotic-interacting motifs suggesting potential secondary 
functions within or distal to infected cells. The multiple forms o f  PmpD could represent 
novel vaccine or drug targets. Taken together, these data implicate PmpD as a 
multifunctional virulence factor important in chlamydial pathogenesis.
Overall, these findings have contributed meaningful information related to the structure 
and function o f  CT153 and PmpD that will be useful for guiding future studies to 
determine their distinct roles in chlamydial pathogenesis.
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2020 that strategically  aim s to eradicate b lind ing  trachom a by  focusing on eyelid surgery, 
antibiotics to treat infection, facial cleanliness and environm ental changes. The m ost 
effective strategy for controlling chlam ydial STI is vaccination. Identifying and 
characterizing virulence factors involved in the pathogen-host relationship is essential for 
designing therapeutic interventions and targeting  potential antigens for vaccine 
developm ent.
The surface com ponents o f  the infectious chlam ydial elem entary body  (EB) are 
critical in initial interactions leading to productive host cell invasion and are a logical 
place to look for targets o f  protective antibodies. A ntibodies directed against the m ajor 
outer m em brane protein (M O M P) and a m em ber o f  the polym orphic m em brane protein 
(Pm p) family, Pm pD , neutralize chlam ydial infectivity  in vitro  (Caldw ell and Perry, 
1982; C rane et al., 2006). M OM P has been extensively  studied due to its abundance and 
im m unogenicity, but it is the serologically  variable antigen that defines the different 
serovars. Pm pD is highly conserved am ong the strains and is a target o f  broadly  cross­
reactive neutralizing antibodies m aking it an attractive candidate for the developm ent o f  a 
vaccine for prevention o f  hum an infections (Crane et al., 2006). E lucidating the structure 
and function o f  Pm pD  is an im portant step tow ard this end. M y dissertation research has 
focused on characterizing two chlam ydial proteins that m ay be im portant virulence 
factors and has contributed to understanding the native structure o f  PmpD.
1.1.2 Developm ental cycle
C hlam ydiae are obligatory in tracellu lar pathogens characterized b y  a unique bi- 
phasic developm ental cycle consisting o f  tw o distinct m orphological forms. An 
illustrated overview  o f  the developm ental cycle is show n in Fig. 1. This figure and figure 
legend are adapted from  an article by  B elland e t al. (B elland et al., 2003). EBs are small 
(0.3 pm  diam eter) m etabolically  inactive partic les that initiate infection by  attaching to 
eukaryotic host cells and inducing their ow n uptake at the p lasm a m em brane. 
Chlam ydial cells rem ain confined to a m em brane bound vacuole, term ed an inclusion, for 
the entire cycle. EBs differentiate into m etabolically  active, but non-infectious reticulate 
bodies (RBs) that are larger in size (1 pm  diam eter). As RBs grow  and replicate by 
binary fission, the inclusion expands to accom m odate increasing num bers o f  organism s.
The developm ental cycle becom es asynchronous as RBs undergo a secondary 
differentiation to EBs that are released from  the host cell by  inclusion extrusion o r lysis 
to initiate another round o f  infection (M oulder, 1991).
A tta c h m e n t / In v a s io n
R e l e a s e
In c lu s io n
EB • H o s t
h o u r s
R ep l ica t ion
Figure 1. Overview  of the C. 
trachom atis  developm ental 
cycle. The infectious EB is 
internalized by the host cell and by 
8 h differentiates to the
m etabolically active RB. RBs 
replicate by binary fission during 
the m iddle o f the developm ental 
cycle. Late in the cycle the 
organism  undergoes a secondary 
differentiation from  RB to EB. 
Infectious organism s are released 
from the eukaryotic cell to  the 
extracellu lar environm ent and
continue the infectious process in 
neighboring cells. The figure and 
legend are adapted from  Belland 
eta l., 2003.
1.1.3 H ost cell interactions
C hlam ydiae have a com plex intracellular developm ental cycle and interact w ith 
host cells to m anipulate cellular functions and to access nutrients. Studies have begun to 
elucidate the interaction o f  the chlam ydial inclusion w ith cellular organelles and suggest 
C hlam ydia  have evolved sophisticated ways o f  actively associating w ith host cell 
m achinery. D uring entry C hlam ydia  induces reorganization o f  actin and phosphorylation 
o f  host proteins (M ajeed and K ihlstrom , 1991; B irkelund et al., 1994). W ithin  30 mins. 
o f  invasion, the nascent inclusion loses p lasm a m em brane m arkers, d issociates from  the 
endocytic pathw ay (Scidm ore, et al., 2003) and circum vents fusion w ith  lysosom es 
(H einzen et al., 1996). The m olecular m echanism s governing the b iogenesis o f  the 
parasitophorous vacuole are unknow n, but chlam ydial proteins incorporated into the 
inclusion m em brane (Incs) likely function in this capacity  (R ockey et al., 2002). C. 
trachom atis  inclusions recruit the host m otor protein dynein, traffic along m icrotubules to 
the m icrotubule-organizing com plex and rem ain located at the peri-G olgi region o f  the 
cell (G rieshaber et al., 2003). D ifferent Rab GTPases, w hich are key regulators o f  
m em brane trafficking, are recruited to the inclusion during the developm ental cycle, yet
inclusion fusion with endosomes is not evident (Rzomp et a l ,  2003). Although the 
inclusion membrane is freely permeable to cytosolic ions such as H+, Na+, K+ and Ca+ 
(Grieshaber et a l ,  2002), chlamydial access to the nutrient-rich host cell cytoplasm is 
limited as the inclusion membrane is impermeable to molecules >520 Da (Heinzen and 
Hackstadt, 1997). Biochemical studies and genomic sequence analysis indicate that 
Chlamydia have undergone reductive genomic evolution and are dependent on host cells 
for metabolic intermediates including lipids, ribonucleotides and amino acids (McClarty, 
1999). Although C. trachomatis encodes a number o f ABC transporter, amino acid 
symporter and permease orthologs (Stephens et al. 1998), the mechanisms by which 
Chlamydia obtain essential biosynthetic constituents has remained elusive.
1.1.4 Lipid acquisition
C. trachomatis have a limited capacity for lipid biosynthesis and retain the genes 
encoding enzymes required for the synthesis o f  phosphatidylethanolamine (PE), 
phosphatidyl glycerol (PG) and fatty acids (Stephens et a l ,  1998). In addition, Chlamydia 
accumulates a variety o f  host-derived lipids during the developmental cycle (Hatch and 
McClarty, 1998; W ylie et al., 1997), but the chlamydial factors that mediate these 
interactions are undefined. Figure 2 summarizes chlamydial lipid acquisition from the 
host cell. The chlamydial inclusion fuses with multivesicular bodies (MVBs; Beatty, 
2006) and sequesters lipid droplet organelles from the cytosol (Cocchiaro et al., 2008) to 
incorporate lysobisphosphatidic acid and neutral lipids, respectively. Chlamydial 
infection induces Golgi fragmentation that is necessary for survival (Heuer et al., 2009), 
and organisms intercept exocytic Golgi-derived vesicles to acquire sphingomyelin (SM) 
and cholesterol (Hackstadt et a l ,  1996; Carabeo et a l ,  2003). The relative contribution 
o f  these pathways to chlamydial acquisition o f  nutrients and biosynthetic precursors other 
than lipids is unclear because protein cargo associated with these vesicles, with the 
exception o f CD63 and MLN64 from MVBs (Beatty, 2006), are not found in the 
inclusion. Phosphatidylinositol (PI), phosphatidylcholine (PC), phosphatidylserine (PS) 
and PG are trafficked to the inclusion by a Golgi-independent mechanism and are 
modified at the inclusion membrane by host phospholipase A. Phospholipase A cleaves 
the sn-2 fatty acid tail, which is replaced by a Chlamydia-synthesized branched chain
e n d o p la s m ic  re tic u lu m  
phosphatidylinosito l 
phosphatidylcholine
m u lt iv e s ic u la r  b od y  
sphingom yelin 
cholesterol 
lysobisphosphatid ic aci
n u c le u s
sphingom yelin
cholesterol
inclusion
lip id  d ro p le ts  
neutra l lip ids 
phosphatidylcho line
h os t
phosphatidylglycerol 
phosphatidylethanolam ine 
phosphatidylserine
m ito c h o n d r ia
cardiolipin
Figure 2. Sum m ary of lipid acquisition in C. 
trachomatis. The lipid composition of purified EBs 
mimics that of the infected host cell indicating that 
Chlamydia can access host-derived lipids from a number 
of cellular sources. C. trachomatis retains the 
biosynthetic capacity to synthesize PE and PS, but lack 
the genes required for SM, PI, PC, cholesterol, and 
cardiolipin implying they are acquired directly from the 
host cell. The organelles and resident lipid species are 
listed. Question marks indicate that the mechanism of 
acquisition is undefined. The Chlamydia-synthesized 
branched chain fatty acid is shown in red. PLA, 
phospholipase A.
remain largely undescribed.
fatty acid (Wylie et al., 1997). 
The source o f  these
glycerophospholipids is
unknown, but PI and PC are 
synthesized in the endoplasmic 
reticulum and cardiolipin is 
exclusive to the mitochondria. 
The inclusion membrane
protein, IncA (Cocchiaro et al., 
2008), chlamydial Lda proteins 
(Kumar et al., 2006) and the 
phospholipase D (PLD) 
paralogs (Nelson et al., 2006) 
have been implicated in lipid 
acquisition, but the 
mechanisms through which 
Chlamydia target and 
assimilate specific host lipids
1.2 Comparative genomics
The chlamydial developmental cycle is unique among prokaryotes and presents 
formidable challenges in the study o f  chlamydial biology and pathogenesis. The obligate 
intercellular niche has precluded the establishment o f  a cell-free growth system to study 
chlamydial metabolism by standard biochemical approaches. Despite considerable 
efforts, the development o f  a tractable system for genetic manipulation has proven to be 
exceedingly difficult with major advancements on this front occurring only within the last 
year (Binet and Maurelli, 2009). A lack o f  chlamydial genetics means that the ability to 
specifically knock out or mutate a gene and restore the function by genetic 
complementation is not currently feasible. Chlamydiae are evolutionarily deeply
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separated from other eubacteria (W eisburg et a l ,  1986) and this limits the utility o f 
surrogate systems in other species to study the function o f  chlamydial proteins.
To overcome these hurdles chlamydial genomes from a diverse spectrum o f  host- 
specific strains have been sequenced (Azuma et a l., 2006; Carlson et a l., 2005; Kalman et 
al., 1999; Read et al., 2000; Read et al., 2003; Shirai et al., 2000; Stephens et al., 1998; 
Thomson et al., 2008; Thomson et al., 2005). Comparative genomic analysis have shed 
light on the molecular basis o f  pathogenic diversity in chlamydiae and have provided 
important insights into shared and species-specific virulence factors (Carlson et al., 2005; 
Kalman et al., 1999; Kari et al., 2008; Read et al., 2000, Read et al., 2003; Stephens et 
al., 1998; Thomson et al., 2008). These comparisons demonstrate that Chlamydiaceae 
share a highly conserved core genome that mediates genus common functions such as 
cell division, structural characteristics, and central metabolic pathways. The genetic 
differences among the species and strains provide the basis for specific attributes that 
define the differential biology, host tropism and pathogenesis among the chlamydiae. 
Two groups o f  genes emerged from these analyses that most likely constitute major 
virulence determinants for chlamydiae: i) genes encoded in a hyper-variable region o f  the 
genome, termed the plasticity zone (PZ) and ii) the polymorphic membrane proteins 
(Pmps; Kalman et al., 1999; Read et al., 2000; Stephens et al., 1998). Elucidating the 
contribution o f  these genes to chlamydial pathogenesis will be essential to understanding 
how Chlamydia establish infection, persist in host cells, and evade the human immune 
response. My dissertation research has provided a basic characterization o f a PZ protein 
that varies among chlamydial species and has begun to unravel the structure and function 
o f  polymorphic membrane protein D (PmpD).
1.2.1 The plasticity zone
The human pathogen, C. trachomatis, and the murine pathogen, C. muridarum, 
share a similar developmental biology, but have different host ranges and elicit distinct 
pathology. C. trachomatis exists as 15 serovariants that are further divided into two 
pathobiotypes (trachoma and lymphogranuloma venereum) that exhibit specific 
organotropisms— tropisms for organ-specific disease. For example, serovars L1-L3 
cause STIs that disseminate to the local draining lymph nodes (Schachter, 1978b).
Serovars A -K  that constitute the trachom a biovar are non-invasive and are capable o f 
infecting epithelial cells o f  the conjunctivae and the genital tract (Schachter, 1978c). 
However, only ocular strains (A-C) result in blinding trachom a and only genital strains 
(D-K) cause urogenital STI that leads to upper genital tract d isease (Schachter, 1978a). 
Com parative genom ic analysis has shown that C. trachom atis  and C. m uridarum  share 
rem arkable genom ic synteny and m ore than 99%  orthologous gene content (R ead et al., 
2000). S im ilar studies indicate that trachom a and STI C. trachom atis  serovars share 
m ore than 99.5%  overall nucleic acid sequence identity  (C arlson et a l., 2005; Kari et al., 
2008). A n im portant result o f  these studies is the revelation o f  the underly ing genetic 
basis that m ay dictate the phenotypic differences in chlam ydial host and cellular tropism  
and disease pathology.
V ariation in chlam ydial genom es is clustered to a region o f  the genom e near the 
replication term inus term ed the PZ (Fig. 3; R ead et al., 2000). Recent studies suggest 
that strain- and species-variable alleles in the PZ are d isproportionate players in 
chlam ydial pathogenic diversity  in vivo. The high degree o f  genetic diversity  in the 
chlam ydial PZ m ay  reflect an arm s race betw een chlam ydial virulence factors that 
m ediate im m une evasion, and the sim ultaneous duplication and divergence o f  such 
effector fam ilies in chlam ydial hosts. For exam ple, PZ genes encoding the tryptophan 
biosynthesis operon and chlam ydial cytotoxins are critical to infection tropism  and 
im m une evasion strategies (B elland et al., 2001; Caldw ell et al., 2003; C arlson et al., 
2004; M cC larty  et al., 2007; N elson et al., 2007; N elson et al., 2005). T he a  and (3 
subunits o f  tryptophan synthase are retained in genital strains o f  C. trachom atis  in order 
to circum vent interferon (IFN )-y-dependent depletion o f  intracellular tryptophan pools by 
the synthesis o f  tryptophan from  exogenous indole sources (C aldw ell et al., 2003; 
Fehlner-G ardiner et al., 2002). V ariability  in the cytotoxin is linked to chlam ydial 
resistance to host-specific and tissue-specific IN F-y-inducible G TPases (B elland e t al., 
2001; N elson et al., 2005). N otably, both o f  these chlam ydial im m une evasion strategies 
appear to be strain- and host-specific. T he expanded fam ily o f  PZ PLD  (pzPLD ) genes, 
w hich are putative lipid m odifying enzym es, p lay  an im portant ro le  in chlam ydial 
survival late in the developm ental cycle (N elson et al., 2006). pzPLD s contain an HKD 
m o tif (Ponting and Kerr, 1996; Stephens e t al., 1998) sim ilar to those seen in lipid
modifying enzymes, and may function in chlamydial lipid modification or metabolism. 
In support o f  this hypothesis CT156/Lda-1, a pzPLD, localizes to cytosolic neutral lipid- 
rich structures adjacent to the inclusion membrane (Kumar et al., 2006).
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Figure 3. A rrangem ents o f p las tic ity  zone genes in C. trachom atis, C. m uridarum , and 
C. caviae. ct153  g e n e s  a re  show n in red, p h ospho lipase  D-like family g e n e s  a re  light blue, 
tryptophan biosynthesis g e n e s  a re  colored dark  blue, g e n e s  rela ted  to  the  cytotoxin a re  in 
orange, purine m etabolism  g e n e s  a re  g reen  and  o p en  read ing  fram es in w hite h av e  no 
described  function. D ouble s lan ted  lines and  intervening num bers indicate the  s ize  of 
regions containing g e n e s  of unknown function rem oved from the  d iagram . Full length 
CT153 is en co d ed  in C. trachom atis  and  in C. muridarum , but a b s e n t from C. caviae._________
1.2.2 CT153
Homologs o f  c tl53  are conserved in C. trachomatis strains and are located 
immediately upstream from pzPLDs suggesting these proteins share a concomitant 
function (Carlson et al., 2005; Ponting, 1999; Read et al., 2000; Stephens et al., 1998), 
but the role o f  CT153 in chlamydial biology is unknown. The C-terminal amino acid 
residues 427-621 o f CT153 are strongly homologous to the m embrane attack 
complex/perforin (MACPF) domain o f the lytic components o f  the human immune 
system (Fig. 4; Ponting, 1999; Shinkai et al., 1988). The comparison o f the MACPF 
domain ffom CT153 to human perforin and complement 9 in Figure 4 is adapted from an 
article by Ponting (Ponting, 1999). The MACPF domain o f  perforin and complement 9 
contains the membrane spanning regions that map to two amphipathic a-helices that form 
a helix-loop-helix fimctional m otif (Peitsch et al., 1990). This m otif is highly conserved 
in CT153 (Fig. 4).
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Figure 4. CT153 contains a m em brane attack com plex/perforin dom ain. The C-
terminal region of CT153 (aa 427-621) is strongly hom ologous to the MACPF domain of lytic 
human immune system proteins: perforin (aa 293-369) and com plem ent 9 (aa 166-503). 
The yellow boxes highlight the two predicted am phipathic a-helices o f the helix-loop-helix 
function m otif that is h ighly conserved in CT153. The consensus sequence shows residues 
conserved in all sequences and stars denote residues w ith sim ilar functional/chem ical 
properties. Predicted secondary structure w ith expected accuracies o f >82% are indicated 
as E fo r p-strand or H fo r helix. The figure and legend are adapted from Ponting, 1999.
M any intracellular pathogens take advantage o f  pore-form ing proteins to achieve 
successful host cell colonization, especially during host cell invasion, to facilitate escape 
from  the endocytic pathw ay, for delivery o f  effector m olecules into the host cell or in the 
acquisition o f  nutrients (A lm eida-C am pos e t al., 2002). Both eukaryotes and prokaryotes 
express M A CPF dom ain-containing proteins that either form  lytic pores o r function in 
non-lytic m em brane interactions (R osado et a l ., 2008). Toxoplasm a gondii T gPL Pl 
contains a M A CPF dom ain and form s pores to facilitate parasite egress from  host cells 
(K afsack et al., 2009). Plasm odium  berghei contains several M A C PF-related genes that 
disrupt m em branes to allow  the parasite to transverse host cells (Ishino et al., 2005; 
K adota et al., 2004). The crystal structure o f  P lu-M A C PF from  Photorhabdus  
lum inescens show s that the M A CPF dom ain is structurally  hom ologous to the pore- 
form ing cholesterol-dependent cytolysins o f  G ram -positive bacteria (R osado et al., 
2007). Listeria  m onocytogenes listeriolysin O, a secreted pore-form ing cytolysin, and 
listerial phospholipases m ediate bacterial escape from  the nascent m em brane bound 
vacuole into the host cell cytosol and are essential for m em brane disruption during 
intercellular dissem ination (Cossart et al., 1989; Sm ith et al., 1995). Thus, the presence 
o f  a M ACPF dom ain in CT153 and its linkage w ith the putative lipid m odify ing  pzPLD 
proteins suggest the hypothesis that CT153 in teracts w ith host cell m em branes and shares 
a concom itant function w ith pzPLD s in a species-specific aspect o f  m em brane or lipid
modification (Ponting, 1999). Studies have shown that c tl53  transcripts are expressed 
(Belland et a l ,  2003), but characterization o f  CT153 has not been described in the 
literature. M y dissertation includes a basic characterization o f CT153 as a preliminary 
study to define its function in chlamydial pathogenesis.
1.3 Type V secretion
Pathogenic bacteria interact with host cells by translocating proteins and virulence 
factors to the cell surface or extracellular milieu (Finlay and Falkow, 1997). Gram- 
negative bacteria must translocate proteins across the cell wall, which consists o f  inner 
and outer membranes that sandwich the peptidoglycan and periplasm. Secretion systems 
type I through type VI have evolved to accomplish this task. These different secretion 
strategies range from complex machines composed o f -2 0  subunits like the type III 
secretion system to the type V proteins, which are single polypeptides that function in the 
absence o f  ATP (Gerlach and Hensel, 2007). O f the six independent secretion systems 
described to date, type V secretion is the most widespread and most highly efficient 
pathway employed by Gram-negative bacteria to deliver proteins across both the inner 
and outer membranes (Henderson et a l ., 2004). C. trachomatis encodes a paralogous 
family o f  genes, termed Pmps (Carlson et al., 2005; Stephens et al., 1998; Thomson et 
al., 2008) that have been defined by amino acid sequence analysis as type V secretion 
proteins (Henderson and Lam, 2001). Considering that chlamydiae are fastidious 
organisms undergoing reductive genomic evolution and given the simplicity and 
efficiency o f  the type V secretion pathway, perhaps it is not surprising that this particular 
secretion mechanism has been duplicated and expanded by chlamydiae. The 
identification o f Pmps as type V secretion proteins has underscored their potential as 
virulence factors and has provided insights into their possible structure and function.
The type V secretion family is comprised o f  three classes o f proteins; type Va, the 
autotransporter (AT) system; type Vb, the two-partner secretion pathway and type Vc, the 
trimeric ATs (Fig. 5; Henderson et al., 2004). The classes o f  type V secretion proteins 
are illustrated in Figure 5. All type V secretion proteins are characterized by a common 
configuration that includes: i) an N-terminal signal sequence that directs inner membrane
transport via the Sec secretion m achinery, follow ed by ii) a passenger dom ain (PD) that 
confers effector function, and iii) a conserved outer m em brane anchored (3-barrel that 
facilitates the translocation o f  the PD to the bacterial surface. Type V a A Ts consist o f  a 
single polypeptide that contains all th ree structural com ponents. Sem inal w ork by 
Pohlner et al. on N eisseria gonorrhoeae  IgA l protease provided the first description o f 
the tw o-step secretion m odel (Pohlner et a l ., 1987). A fter Sec-dependent inner 
m em brane transport, the signal sequence is cleaved by  a signal peptidase. T he C- 
term inal am phipathic anti-parallel [3-barrel inserts into the outer m em brane by virtue o f  
an extrem e C-term inal m o tif (Phe proceeded at a periodicity  o f  tw o by  either an arom atic 
or aliphatic am ino acid) and the N -term inal PD is secreted to the surface (H endrixson et
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Figure 5. C lasses o f type V  secretion proteins. The type V secretion fam ily is comprised 
o f three classes o f proteins, the AT system (type Va), the tw o-partner secretion pathway 
(type Vb) and the trim eric ATs (type Vc). All type V secretion proteins are characterized by 
a com m on configuration of an N-term inal signal sequence (white) fo llowed by a diverse PD 
(gold) and a conserved outer mem brane anchored C-term inal (3-domain (red) proceeded by 
a linker region (green). Type Va consists o f a single polypeptide that functions in the outer 
membrane as a m onom er or o ligom er. The PD remains tethered or is cleaved and either 
released or rem ains associated w ith the outer membrane. Type Vb secretion is sim ilar to 
type Va except that the PD and (3-domain are separate polypeptides. In contrast to the 
monom eric (3-barrels o f type Va and Vb, the (3-domain o f type Vc proteins is truncated, and 
three subunits o ligom erize to form  a functional trim er that translocates the PD to the 
bacterial surface.
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a l,  1997). The PD remains tethered to the p-domain or is cleaved and either released or 
remains non-covalently associated with the outer membrane. Processing o f the PD can 
occur by an autocatalytic mechanism (Pohlner et a l ,  1987), or alternatively, via a 
separate membrane bound protease (Egile et a l ,  1997). Neisseria meningitidis NalP 
(Oomen et a l,  2004) and Helicobacter pylori VacA (Lupetti, et a l ,  1996) are examples 
of well-characterized type Va ATs found on the bacterial cell surface that function as 
monomers or oligomers, respectively. ATs are often polarized in the outer membrane 
and function as virulence factors associated with initiating infection, disease progression 
and immune evasion (Dautin and Bernstein, 2007).
1.4 Polymorphic membrane protein D
The Pmp family was first identified on the surface C. psittaci EBs as major 
immunogens, which indicated their potential as protective antigens (Longbottom et a l,  
1996). The genome sequences of several different chlamydial species revealed that the 
pmps are the most numerous and duplicated gene family of Chlamydiaceae (Kalman et 
a l,  1999; Read et a l,  2003; Stephens et a l,  1998). The presence of such a large and 
variable gene family is an indication o f their potential importance for chlamydiae. The 
unifying characteristics o f Pmps are the tetrapeptide sequences o f GG[A/L/V/I][I/L/V/Y] 
and FXXN separated by a variable number of amino acids repeated multiple times 
throughout the N-terminal half of the polypeptides, the predicted P-barrel motif in the C- 
terminal portion of each o f the proteins and their designation as type V ATs (Grimwood 
and Stephens, 1999; Henderson and Lam, 2001). The Pmps exhibit a low degree of 
primary amino acid sequence identity and have variable predicted molecular weights and 
pis ranging from 96 kDa to 187 kDa and 4.3 to 9.1, respectively (Grimwood and 
Stephens, 1999). Phylogenic analysis indicates that Pmps fall into six basic subtypes A, 
B, D, E, G and H suggesting at least six unique functions (Tan et a l,  2006). The function 
of Pmps is largely unknown, but their presence on the chlamydial surface (Crane et a l,  
2006; Knudsen et a l,  1991; Longbottom et a l ,  1998a Longbottom et a l ,  1998b; Mygind 
et a l,  2000), antigenicity (Caldwell et a l ,  1975a; Longbottom et a l ,  1996), extreme 
polymorphism (Carlson et a l,  2005; Kalman et a l, 1999; Stephens et a l ,  1998) and
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genom ic expansion suggests they play  an im portant role in chlam ydial pathogenesis
(Stephens et al., 1998).
C. trachom atis encodes n ine pm p  paralogs {pmpA-I) that constitute 3.2%  o f  the ~1 
Mb genome. This is a significant portion considering that chlam ydiae exhibit a pattern o f  
reductive genom ic evolution in w hich non-essential genes are under selective pressure to 
be deleted. The p m p  genes are found at three chrom osom al loci com prised o f  tw o gene 
clusters {pm pA-C  and pm pE -I) and the genetically  isolated pm pD  (S tephens et al., 1998). 
Pm pD  is the second m ost highly conserved Pm p, exhibiting 99.2%  am ino acid identity 
am ong the serovars (G om es et a l., 2006) suggesting it m ay perform  a critical role in 
chlam ydial pathogenesis. A lthough Pm pD is present in relatively low  abundance in the 
chlam ydial outer m em brane, it is a m ajor im m unogen and thus m ay be im portant 
virulence factor (Caldw ell et al., 1975b). A ntibodies targeting Pm pD are generated 
during the course o f  natural infection in hum ans and in experim entally infected anim als 
(Caldw ell et al., 1975b, C rane et al., 2006). T hese qualities m ake Pm pD  an attractive 
vaccine candidate for the prevention o f  hum an infections.
Pm pD  is expressed by all C. trachom atis serovars, localizes to the infectious EB 
surface and is the target o f  neutralizing antibodies (C rane et al., 2006). Pm pD  undergoes 
proteolytic processing (K iselev et al., 2007), but the significance o f  this m odification is 
not understood. T he C. pneum oniae  Pm pD  ortholog is a proteolytically  processed 
surface protein that has been suggested to function as an adhesin (V andahl et al., 2002; 
W herl et al., 2004) and induces pro-inflam m atory cytokine production (N iessner et al., 
2003). B ecause o f  the potential im portance o f  Pm pD in chlam ydial pathogenesis a better 
understanding o f  the structure and function o f  the native protein is w arranted. The 
research presented here provides structural inform ation show ing that Pm pD  exists as a 
higher-ordered structure on the organism ’s surface and as soluble form s produced late 
during infection im plicating Pm pD as a m ultifunctional protein im portant to chlam ydial 
pathogenesis.
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1.5 R esearch goals and significance
Effective control o f  blinding trachom a and chlam ydial sexually  transm itted 
diseases will likely require a preventative vaccine (Brunham  et al., 2005). O ur approach 
is to identify the genetic basis o f  chlam ydial diversity, understand the function o f  these 
genes in chlam ydial pathogenesis and target these proteins as vaccine candidate antigens. 
Com parative genom ic analyses indicate that Chlam ydiaceae  species share a highly 
conserved genetic core and that genes located in the PZ and m em bers o f  the Pmp fam ily 
represent determ inants o f  strain-variability and thus are potentially  im portant virulence 
factors (C arlson et al., 2005; K alm an et al., 1999; Read et al., 2000, R ead et al., 2003; 
Stephens et al., 1998; T hom son et al., 2008). The goals o f  m y dissertation research have 
been focused on understanding the structure and function o f  a m em ber from  each o f  these 
fam ilies. B iochem ical and cellular biological approaches w ere utilized to begin to 
elucidate the role o f  the PZ M A CPF dom ain containing protein CT153 in chlam ydial 
pathogenesis. Im m unochem ical and biochem ical techniques w ere em ployed to elucidate 
the native structure o f  PmpD, w hich is a highly conserved vaccine candidate antigen.
PZ genes are disproportionate players in infection tropism  and im m une evasion 
strategies (B elland et al., 2001; Caldw ell et al., 2003; M cC larty et al., 2007; N elson et 
al., 2007; N elson et al., 2005). C hapter tw o provides a basic biological characterization 
o f  the PZ M A CPF dom ain containing protein CT153 utilizing biochem ical and cellular 
biological m ethodology. CT153 w as found w ithin a distinct subset o f  RBs associated 
w ith the inner leaflet o f  the inclusion m em brane in jux tanuclear regions o f  the inclusion 
suggesting RBs that perform  specialized functions exist late during infection. Large 
atypical RBs expressing CT153 w ere in d irect contact w ith host acquired intra-inclusion 
lipid droplets. These results support the hypothesis that CT153 is involved in a species- 
specific aspect o f  chlam ydial acquisition o f  host-derived lipids. T his dissertation 
research has provided the first characterization o f  CT153 and should be useful as a 
prelim inary study for further investigation focused on defining its function in chlam ydial 
pathogenesis.
C. trachom atis  Pm pD is an attractive vaccine candidate as it is conserved am ong 
C. trachom atis strains and is a target o f  broadly cross-reactive neutralizing antibodies
(Crane et al., 2006). C hapter three describes the native structure o f  Pm pD  and provides 
insights into the function o f  Pm pD during infection. Em ploying im m unochem ical and 
biochem ical techniques this research show s that native Pm pD exists as two distinct 
fonns. The first form is an outer m em brane associated flow er-like oligom er, com posed 
o f  the full length polypeptide and two proteolytically  processed fragm ents, w hich is 
involved in the initial stages o f  host cell invasion (Crane et a l., 2006). T he characteristics 
o f  this higher-ordered structure are strikingly sim ilar to the rosettes on  the surface o f  the 
EB described over th irty  years ago in a series o f  elegant electron m icroscopy studies by 
M atsum oto and others (C hang et al., 1982; G regory et al., 1979; M atsum oto, 1982a; 
M atsum oto, 1982b; S o loff et al., 1982). This research suggests that the rosette structures 
represent Pm pD  and possibly other chlam ydial type V secretion proteins. D uring the late 
stages o f  infection Pm pD undergoes secondary proteolytic processing resulting in soluble 
polypeptides that contain putative eukaryotic interacting functional m otifs. The soluble 
form s o f  Pm pD could function late during infection by accessing the host cell cytosol or, 
they m ight be released follow ing inclusion extrusion or host cell lysis (Todd and 
Caldwell, 1985) to interact w ith neighboring epithelial cells o r local im m une cells. 
C ollectively, these data im plicate Pm pD  as a m ultifunctional virulence factor im portant 
in chlam ydial pathogenesis. Further, these findings suggest that an efficacious Pm pD - 
based subunit vaccine m ay require the incorporation o f  all fonns o f  Pm pD in order to 
induce antibodies capable o f  neutralizing the m ultiple Pm pD activities.
A greater understanding o f  the chlam ydial proteins m ediating im m une evasion, 
persistent grow th, and pathogenesis will be essential for the developm ent o f  therapies and 
a vaccine that w ill control hum an chlam ydial diseases. The research described in these 
dissertation projects offers im portant insights into the structure and function o f  two 
different proteins that have distinct roles in chlam ydial pathogenesis. This w ork provides 
the first description o f  CT153 and suggests that a subset o f  RBs exist late during infection 
possibly to perform  specialized functions. T he findings that Pm pD  exists as higher- 
ordered oligom ers and undergoes secondary processing to produce soluble form s have 
not been previously described in the literature. These studies point tow ard a w orking 
m odel o f  Pm pD as a m ultifunctional virulence factor. Both o f  these projects provide
m eaningful inform ation that will be useful for guiding future studies to determ ine the role 
o f  both CT153 and Pm pD in chlam ydial pathogenesis.
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CH A PTER TW O 
CH A RA CTERIZA TIO N  OF CHLAM YDIA TRACH O M ATIS  
PLA STICITY  ZO N E M EM B RA N E A TTA C K  CO M PLEX /PER FO R IN  DOM A IN
FAM ILY PRO TEIN  CT153
2.1 Abstract
Chlam ydia trachom atis are obligate intracellular hum an pathogens that share near 
genom ic synteny, but exhibit distinct infection and disease organotropism s. The genetic 
basis for this unique pathogen-host relationship is associated w ith genes located in a 
small hyper variable region o f  the genom e term ed the p lasticity  zone (PZ). PZ encoded 
proteins CT153 and an expanded phospholipase D -like (PLD ) fam ily o f  proteins w ith 
putative lipid hydrolyzing activity have unknow n functions. H ere w e describe a basic 
biological characterization o f  CT153 as an initial step in defin ing its role in chlam ydial 
pathogenesis. W e show that CT153, w hich contains a C -term inal putative m em brane- 
spanning m em brane attack com plex perforin dom ain, is expressed as a full length 91 kD a 
polypeptide in elem entary bodies in all 15 hum an serovariants im plicating a com m on 
function. CT153 is processed in infected cells into polypeptides o f  59 and 42 kDa. 
Sim ilar processing is also observed follow ing expression o f  recom binant CT153 in 
Escherichia coli suggesting autocatalytic proteolysis. Im m unoelectron m icroscopy 
revealed that CT153 shared localization patterns w ith Hsp60 and CT155, a PLD hom olog 
flanking CT153 in the PZ. CT153 stain ing w as restricted to reticulate bodies (RBs) 
adjacent to the inclusion m em brane and to large m orphologically  atypical RBs. RBs 
expressing CT153 tended to associate w ith intra-inclusion lipid droplets w hereas, RBs o f 
a strain lacking CT153 and the PLDs did not. C ollectively, our findings suggest C. 
trachom atis CT153 and the PZ PLDs share a concom itant function involving lipid 
m etabolism  or acquisition that associates w ith a subpopulation o f  RBs.
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2.2 Introduction
Chlam ydia trachom atis is a G ram -negative obligate intracellular pathogen that is 
the cause o f  trachom a and sexually transm itted infections in hum ans. C hlam ydiae have a 
unique bi-phasic developm ental cycle in w hich the infectious, m etabolically  inactive 
elem entary body (EB) invades host cells and rem ains restricted w ithin a m em brane bound 
vacuole, term ed an inclusion. EBs differentiate into m etabolically active, but non- 
infectious reticulate bodies (RBs) that grow  and replicate by  binary fission. RBs undergo 
a secondary differentiation to EBs that are released from  the host cell to initiate another 
round o f  infection (M oulder, 1991). C. trachom atis  accum ulates host-derived lipids 
during the intracellular phase o f  its developm ental cycle b y  a variety  o f  distinct routes 
(Hatch and M cClarty, 1998; W ylie e t a l., 1997). Chlamydia  induces Golgi fragm entation 
(H euer et al., 2009) and intercepts G olgi-derived exocytic vesicles (H ackstadt, 1996) 
w hereby the pathogen acquires cholesterol, sphingom yelin and possib ly  other nutrients. 
Chlam ydial inclusions can fuse w ith m ultivesicular bodies (M V Bs) (Beatty, 2006) and 
sequester lipid droplet (LD) organelles from  their host cells (Cocchiaro et al., 2008). The 
inclusion m em brane protein, IncA (Cocchiaro et al., 2008), chlam ydial Lda proteins 
(K um ar et al., 2006) and the phospholipase D (PLD) paralogs encoded in the p lasticity  
zone (PZ) (N elson et al., 2006) have been im plicated in lipid acquisition, but m echanism s 
through w hich Chlam ydia  target and assim ilate specific host lipids rem ain largely 
undescribed.
The genom es o f  several chlam ydial species have been fully sequenced (A zum a et 
al., 2006; Carlson et al., 2005; Kalm an et al., 1999; Read et al., 2000; R ead et al., 2003; 
Shirai et al., 2000; Stephens et al., 1998; T hom son et al., 2008; T hom son et al., 2005) 
and recent advances in our understanding o f  the m olecular basis o f  the pathogenic 
diversity in the Chlam ydiaceae  have been strongly influenced by com parative genom ic 
analysis. For exam ple, various C. trachom atis strains (all hum an pathogens) and the 
m urine pathogen, C. muridarum, share rem arkable genom ic synteny and m ore than 99%  
orthologous gene content (Read et al., 2000). Substantial pathogenic diversity  is evident 
in at even finer levels o f  phylogenic separation. C. trachom atis serovariants that elicit 
trachom a and sexually transm itted disease share m ore than 99.5%  overall nucleic acid
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sequence identity (Carlson et al., 2005; Kari et al., 2008). These and similar comparisons 
demonstrate that Chlamydiaceae share a highly conserved core genome which mediates 
genus common functions such as metabolism and cell division. Variation in chlamydial 
genomes is clustered to a hyper variable region o f the genome termed the PZ (Read et al., 
2000), and recent studies suggest that strain- and species-variable alleles in the PZ are 
disproportionate players in chlamydial pathogenic diversity in vivo. The high degree o f 
genetic diversity in the chlamydial PZ may reflect an arms race between chlamydial 
virulence factors that mediate immune evasion, and the simultaneous duplication and 
divergence o f such effector families in chlamydial hosts. For example, PZ genes 
encoding the tryptophan biosynthesis operon and chlamydial cytotoxins are critical to 
infection tropism and immune evasion strategies (Belland et al., 2001; Caldwell et al., 
2003; Carlson et al., 2004; McClarty et al., 2007; Nelson et al., 2007; Nelson et al., 
2005). Notably, both o f  these chlamydial immune evasion strategies appear to be strain- 
and host-specific. The expanded family o f  PZ phospholipase D (pzPLD) genes, which 
are putative lipid modifying enzymes, play an important role in chlamydial survival late 
in the developmental cycle (Nelson et al., 2006). pzPLDs contain an HKD m otif 
(Ponting and Kerr, 1996; Stephens et al., 1998) similar to those seen in lipid modifying 
enzymes, and may function in chlamydial lipid modification or metabolism. In support 
o f this hypothesis CT156/Lda-1, a pzPLD, was recently shown to localize to cytosolic 
neutral lipid-rich structures adjacent to the inclusion membrane (Kumar et al., 2006).
CT153 orthologs are conserved in C. trachomatis strains and are located 
immediately upstream from pzPLDs suggesting these proteins share a concomitant role in 
pathogenesis (Carlson et al., 2005; Ponting, 1999; Read et al., 2000; Stephens et al., 
1998; Thomson et al., 2008), but the function o f  CT153 is unknown. The C-terminal 
amino acid residues 427-621 o f  CT153 possess strong homology to the membrane attack 
complex/perforin (MACPF) domain (Ponting, 1999). The MACPF domain o f  perforin 
and complement 9 contains membrane spanning regions that map to two amphipathic a - 
helices that form a helix-loop-helix functional m otif (Peitsch et al., 1990). This m otif is 
highly conserved in CT153 (Ponting, 1999). M ACPF domain-containing proteins from 
Toxoplasma and Plasmodium  form pores to facilitate parasite egress from cells (Kafsack 
et al., 2009) and disrupt membranes to allow the parasite to transverse host cells (Ishino
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et a l ,  2005; Kadota et a l ,  2004), respectively. The crystal structure o f  Plu-MACPF 
protein from Photorhabdus luminescens demonstrated that the MACPF domain of this 
protein is similar to the pore-forming cholesterol-dependent cytolysins o f Gram-positive 
bacteria (Rosado et al., 2007). Listeria monocytogenes listeriolysin O, a secreted pore- 
forming cytolysin, and listerial phospholipases mediate pathogen escape from the nascent 
membrane bound vacuole and disrupt host membranes during intercellular dissemination 
(Cossart et a l ,  1989; Smith et a l ,  1995). Thus, both the presence o f  a MACPF domain 
in CT153 and its linkage with the putative lipid modifying pzPLD proteins suggest the 
hypothesis that CT153 may interact with host cell membranes (Ponting, 1999).
W hole genome transcriptome analysis o f the C. trachomatis developmental cycle 
showed that ct!53  transcription initiates by 8 h and peaks by 24 h following infection 
(Belland et a l ,  2003), an interval that correlates with RB replication during the 
developmental cycle. Here we provide the first description o f C. trachomatis CT153 and 
show the protein is expressed mid-developmental cycle and undergoes infection- 
dependent proteolytic processing. We show that CT153 localizes to RBs located at the 
inclusion membrane interface and to large atypical RBs in the inclusion lumen. Finally 
we show that the presence o f  CT153 and the pzPLDs in the genome is positively 
correlated with the ability to accumulate intra-inclusion LDs. Our findings suggest 
CT153 plays a strain-specific role in the acquisition or modification o f  host-derived 
lipids.
2.3 Materials and Methods
2.3.1 Cell culture and chlamvdiae infections.
C. trachomatis serovars A/Har-13, B/TW-5/OT, Ba/Ap-2, C/TW -3/OT, D/UW- 
3/Cx, E/Bour, F/IC-Cal-3, G/UW-524/Cx, H/UW-4/Cx, I/UW-12/Ur, J/UW-36/Cx, 
K/UW-31/Cx, Ll/LGV-440, L2/LGV-434, L3/LGV-404, C. muridarum  strain Weiss 
(MoPn), C. pneumoniae strain AR-39, C. caviae strain guinea pig inclusion conjunctivitis 
(GPIC), C. psittaci strains Mn Cal-10 and 6BC were propagated and purified from HeLa 
229 cells as previously described (Caldwell et a l ,  1981). EBs and RBs were purified by 
Renografin density gradient centrifugation as previously described (Caldwell et a l ,  1981;
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Swanson et a l , 2009). Total protein concentrations o f  the purified EBs w ere m easured 
by bicinchoninic acid assay (Therm o Fisher Scientific, Rockford, IL). Chlam ydial 
infections were perform ed in HeLa 229 cells. M onolayers w ere w ashed tw ice with 
H ank’s balanced salt solution (HBSS) w arm ed to 37°C and inoculated w ith density 
gradient purified EBs in ice-cold sucrose-phosphate-glutam ic acid buffer (SPG) or mock- 
infected w ith SPG. Plates were centrifuged at 545 x g  at 20°C for 1 h, rocked at 37°C for 
30 m in., washed tw ice w ith 0.5 ml HBSS warm ed to 37°C, fed w ith w arm  Dulbecco s 
m odified Eagle’s m edium  containing 10% fetal bovine serum , 2 m M  L-glutamine, 10 
mM  HEPES, 1 mM  sodium  pyruvate, 55 pM  (3-mercaptoethanol and 10 pg/m l 
gentam icin (M D M EM -10), then incubated at 37°C in 5% C 0 2. For M VB inhibition 
assays 1, 5, or 10 m M  3-m ethyladenidne (3-M eA ) w as added to infected cells at 1 h post 
infection as described (Beatty, 2006). L929 suspension cells were propagated, infected 
and harvested as previously described (Caldw ell et al., 1975; Swanson et al., 2009).
2.3.2 Cloning, expression and purification o f  C T 153.
The c tl5 3  allele from  C. trachom atis serovar D genom ic DN A was am plified by 
polym erase chain reaction (PC R) using prim ers CT153A  (5’- 
C ACC AT G A C T A A G C C TT C TTT C TT AT ACG-3 ’) and CT153B (5 ’-
A T A A C C TG A A G A TTTT TTA A TA A TA A A G A TA G C -3’). The resulting PCR product 
was cloned in fram e into the G atew ay vector, pEN TR /SD /D -TO PO  (Invitrogen, 
Carlsbad, CA), and w as subcloned into pEX P2, a prokaryotic expression vector 
containing a C-term inal 6X  histidine tag  and a 14 am ino acid V5 epitope for purification 
and detection (Invitrogen, Carlsbad, CA). The final vector was confirm ed by restriction 
digest and by DNA  sequencing. BL21 (DE3) Escherichia coli (Invitrogen, Carlsbad, 
CA) w ere transform ed and induced w ith isopropyl-[3-D-thiogalactopyranoside during 
m id-log growth. Cultures w ere harvested by  centrifugation 12 h after protein expression 
was induced. Cell pellets were resuspended in phosphate buffered saline (PBS), pH 7.2, 
extracted by sonication and centrifuged to obtain insoluble and soluble fractions. 
Recom binant CT153 (rCT153) was batch  purified from  the soluble fractions by 
im m obilized m etal affinity  chrom atography (IM A C) using cobalt resin as described by
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the m anufacturer’s non-denaturing protocol (BD Biosciences, San Jose, CA) and was 
eluted from the colum n using a step gradient o f  increasing im idazole concentrations.
2.3.3 G eneration o f  anti-CT153 antibodies.
Pooled elution fractions from  IM AC w ere concentrated, separated by  SD S-PA G E 
and stained w ith G elCode Blue (Therm o Fisher Scientific, R ocktord, IL). The three 
predom inant eluted polypeptides at 95 kDa, 63 kDa, and 46 kD a w ere excised, digested 
w ith trypsin and subjected to m atrix-assisted laser desorption/ionization-tim e o f  flight 
(M A LD I-TO F) m ass spectrom etry analysis to confirm  identity (Scripps C enter for M ass 
Spectrom etry, La Jolla, CA). The N ational Institute o f  A llergy and Infectious Disease 
Anim al Care and U se Com m ittee approved all animal experim ents, w hich were 
perform ed according to protocol. 2 p g  o f  purified rCT153 em ulsified in 0.2 ml o f  Ribi 
adjuvant system  M PL+TD M  em ulsion (Corixa, H am ilton, M T) was used to 
subcutaneously im m unize six 8-12 w k old fem ale BALB/c m ice as previously  described 
(N elson et a l ., 2006). Sera w ere collected and antibody (Ab) specificity  was confirm ed 
by W estern blot o f  purified EBs, and titers w ere determ ined by enzym e-linked 
im m unosorbent assay using rCT153.
2.3.4 SD S-PA G E and W estern blot.
For SDS-PA G E, sam ples w ere boiled for 10 min. at 100°C in Laem m li buffer and 
(3-mercaptoethanol, then electrophoresed on 10% or 4-15%  Criterion precast gels (Bio- 
Rad, Hercules, CA). For W estern blots, a C riterion B lotter (B io-Rad, H ercules, CA) was 
used to transfer proteins from  gels to 0.2 pm  nitrocellulose in sodium  phosphate buffer at 
100 V for 35 min. The nitrocellulose w as blocked at room  tem perature (RT) for 2 h in 
PBS containing 3%  bovine serum  album in (BSA), 0.05%  Tw een-20 and 0.02%  N aN 3 , 
then incubated w ith designated prim ary Abs at RT overnight. Blots w ere washed 
extensively w ith PBS containing 3%  BSA and 0.05%  Tw een-20, then incubated at RT for 
2 h w ith goat anti-m ouse horseradish peroxidase-conjugated secondary Ab (1:1000 
dilution; M P Biom edicals, Solon, OH). The im m unoblots w ere w ashed three tim es w ith 
PBS containing 0.05%  Tw een-20, rinsed tw ice w ith PBS, then developed w ith 4-chloro- 
1-napthol and H2 O 2 .
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2.3.5 Im m unodot blot.
Im m unodot blot was perform ed as previously described (Crane et al., 2006). 
Briefly, C. trachom atis serovar D EB w ere applied to a nitrocellulose m em brane using a 
Bio-Dot SF m icrofiltration apparatus (B io-Rad, Hercules, CA) and probed w ith tw o-told 
dilutions o f  anti-M OM P (B-B5b), anti-LPS (EV IH I), and anti-H sp60 (A 57), anti-CT153 
Abs o r preim m une sera as prim ary Abs. Blots w ere probed w ith horseradish peroxidase- 
conjugated secondary Abs (M P Biom edicals, Aurora, OH) and developed using 3,3 ,5,5 - 
tetram ethylbenzidine single solution (Invitrogen Carlsbad, CA) as substrate according to 
the m anufacturer’s instructions.
2.3.6 Tem poral kinetics o f  CT153 expression.
HeLa 229 cells w ere grow n overnight to confluent m onolayers in six well plates 
and infected o r m ock infected in duplicate as described above. A t 0, 2, 4, 8, 16, 24, 36, 
48 and 60 h post infection, m onolayers w ere w ashed tw ice w ith 0.5 ml H ank’s balanced 
salt solution w arm ed to 37°C and solubilized in 300 p i o f  Laem mli buffer and (3- 
m ercaptoethanol warm ed to 56°C. Sam ples w ere prepared for SD S-PA G E and W estern 
blot as described above using anti-CT153 (1:500 dilution), anti-m ajor outer m em brane 
protein (M O M P) (B-B5b; 1:200 dilution) o r anti-glyceraldehyde 3-phosphate
dehydrogenase (GA PD H ; 1:5000 dilution) (A beam , Cam bridge, M A ) as prim ary Abs.
2.3.7 CT153 solubility.
C. trachom atis serovar L2 infected L929 suspension cell cultures w ere harvested 
at 0, 12, 24, 30 and 36 h  post infection, sensitized w ith hypo-osm otic sw elling buffer and 
gently  lysed w ith a dounce hom ogenizer to >90%  lysis. Cell lysates w ere prepared using 
ultra centrifugation to separate insoluble and soluble fractions as perviously described 
(Fan et a l ., 1998; Swanson et al., 2009). Insoluble and soluble fractions w ere analyzed 
by W estern blot using anti-CT153 (1:500 dilution), anti-M O M P (B-B5b; 1:10,000 
dilution) or anti-chlam ydial protease-like activity factor (CPAF; 1:50 dilution) (D ong et 
al., 2004) prim ary Abs.
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2.3.8 Transfection o f  H eLa cells w ith CT153-GFP.
The pEN TR /SD /D -TO PO  containing the c tl5 3  allele was subcloned into pcD NA- 
DEST47 (Invitrogen, Carlsbad, CA), a eukaryotic expression vector containing a CM V 
prom oter to drive expression o f  a C-term inal cycle 3 m utant o f  green fluorescent protein 
(GFP) fusion protein. The plasm id was purified using a Q iagen EndoFree plasm id maxi 
kit (Q iagen, V alencia, CA) and confirm ed by  restriction digest and D NA sequencing. 
Low passage HeLa 229 cells (passage 3-12) w ere plated at various densities on 24 well 
glass bottom  plates (Greiner-Bio-O ne, M onroe, N C ) and grown to ~50-80%  confluency. 
C ells were transfected w ith pcD N A -D EST47-CT153 (C T153-G FP) using FuGENE6 
(Roche, Indianapolis, IN) according to the m anufacturer’s protocol. Briefly, 3 o r 6 p i o f  
FuGENE6 reagent was incubated w ith serum  free M D M EM  for 5 m in., 1 pg  o f  plasm id 
DNA was added and incubated at RT for 20 min. 20 pi o f  reagent:D N A  m ixture was 
added to the sub-confluent m onolayers in a drop w ise m anner and the plates w ere 
incubated at 37°C in 5% C 0 2. pcD N A /G W -47/C A T (CAT-GPF) (Invitrogen, Carlsbad, 
CA) and lysosom e-associated m em brane protein 1 -m onom eric green fluorescent protein 
(L A M Pl-m G FP) (Falcon-Perez et al., 2005) w ere used as positive controls. Transfected 
cells were visualized at various tim es follow ing transfection using a N ikon Eclipse 
TE2000-S m icroscope (Nikon, Tokyo, Japan) equipped w ith filters to specifically detect 
the cycle 3 m utant o f  GFP (3607. excitation filter— 40 nm band pass and 5357. em ission 
filter— 40 nm band pass) and the m GFP (4807. excitation filter— 30 nm  band pass and 
5357. em ission filter— 40 nm band pass). Fluorescence was detected using a 
Photom etries CoolSN A P HQ2 cam era (Princeton Instrum ents, Trenton, NJ). All im ages 
were processed using A dobe Photoshop.
2.3.9 Confocal m icroscopy and lipid droplet staining.
For CT153 tem poral localization, C. trachom atis serovar D infected H eLa cells 
w ere fixed at different tim es post infection in 2%  paraform aldehyde (PFA ) and 
perm eabilized w ith 0.2%  saponin. Indirect im m unofluorescence was perform ed using 
anti-CT153 m ouse A bs (1:500 dilution) and anti-EB rabbit serum  (1:200 dilution), 
follow ed by A lexaFluor-conjugated secondary Abs (1:800 dilution; M olecular Probes, 
Eugene, OR). Labeled coverslips w ere w ashed extensively, stained w ith 5 pM  Draq5
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concentrations (Fig. 6, lanes 1-4). The m ajority  o f  bound rCT153 was eluted in the first 
two im idazole fractions along w ith tw o less abundant polypeptides w ith m asses o f  63 
kD a and 46 kDa. The 95 kDa, 63 kD a and 46 kD a polypeptides w ere identified as 
CT153 by M A LD I-TO F m ass spectrom etry (data not shown). Sequence analysis 
indicated that the p46 and p63 tryptic peptide fragm ents m ap to the N -term inal and the C- 
term inal portions o f  CT153, respectively. T hereby p63 contains the M ACPF dom ain. 
Thus, CT153 is partially degraded into two polypeptide fragm ents that approxim ate the 
m ass o f  the m ature full length protein, suggesting that it had undergone autocatalytic 
proteolysis during purification. The full length and the p63 w ere also strongly reactive 
w ith anti-V5 Ab by  W estern blot analysis (Fig. IB ) confirm ing these polypeptides 
corresponded to full length and a processed form  o f  rC T l 53.
Coomassie anti-V5 epitope
Figure 6. Purification of recom binant CT153. C. trachom atis CT153 was cloned into a 
prokaryotic expression vector, pEXP2, expressed and purified by immobilized metal affinity 
chrom atography. Fractions from each step of the purification process were analyzed by (A) 
Coom assie stained SDS-PAGE gel and (B) W estern blot w ith anti-V5 Ab. rCT153 was 
highly homogenous in the recovered elution fractions and undergoes proteolytic processing. 
W hite box highlights expressed rCT153. U, uninduced cell lysate; I, induced cell lysate; P, 
pellet; S, supernatant; F, flow th rough .____________________________________________________
g
elution elution
fractions fractions
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p95
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2.4.2 Characterization o f  anti-CT153 sera.
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The sera from m ice im m unized w ith rCT153 w ere characterized by  W estern 
blotting to define its antigenic specificity and reactivity  against m ultiple chlam ydial 
strains. The com plete genom e sequences o f  C. trachom atis serovars A, D, and L2 show 
that CT153 is retained in the PZ o f  these strains (Carlson et al., 2005; Stephens et a l., 
1998; Thom son et a l 2008); how ever, it is not know n w hether CT153 is present in other 
hum an strains. Equivalent am ounts o f  highly purified EBs from  15 C. trachom atis 
reference serovars, C. m uridarum , C. caviae, C. pneum oniae  and 2 C. psitta c i strains 
w ere analyzed by  SD S-PA G E (Fig. 7A) and by W estern b lo t using anti-CT153 serum 
(Fig. 7B). A band at the expected m olecular w eight was not discernible in a C oom assie 
stained gel (Fig. 7A) indicating CT153 was not abundant in EBs. Anti-CT153 Abs 
reacted w ith a single polypeptide o f  the predicted m olecular m ass o f  91 kD a in all 15 
hum an serovar EB lysates, dem onstrating that CT153 is expressed by  these strains. The 
relative am ount o f  C T 153, as determ ined by  blot intensity, was greater in trachom a (A-K) 
com pared to lym phogranulom a venereum  (LG V ; L1-L3) biovar strains. Surprisingly, 
anti-CT153 serum  did not recognize the CT153 C. m uridarum  PZ ortholog despite the 
high degree o f  aa identity (70% ) betw een the proteins, arguing that the im m unodom inant 
region(s) o f  CT153 reside in regions o f  aa diversity  rather than hom ology. Consistent 
w ith the genom ics the anti-CT153 A bs did not react w ith C. pneum oniae, C. caviae, C  
psittaci (M n) or C. psittac i (6BC).
-C T 1 5 3
Figure 7. Characterization of anti-CT153 sera. Highly purified EBs from C. trachomatis  
serovars (A-L3), C. m uridarum  (MoPn), C. caviae  (GPIC), C. pneum oniae  (CPn), and 2 C. 
psittaci strains (Mn and 6BC) w ere standardized fo r equal protein loading, separated by SDS- 
PAGE, blotted to nitrocellulose and probed w ith anti-CT153 Abs. CT153 was not abundant by 
(A) Coom assie stained gel, but was detected by (B) W estern blot in the EBs of all 15 human 
serovars (A-L3). The Ab failed to detect the CT153 ortholog in C. muridarum.
C oom assie anti-CT153
2.4.3 CT153 is not surface-exposed.
Immunodot blots o f EBs and neutralization o f infectivity assays were performed 
to test if  CT153 was present on the surface o f EBs. Immunodot blots showed that the 
predominant surface antigens, MOMP and LPS, were exposed on the EB outer 
membrane; in contrast, the cytoplasmic protein, Hsp60, was not detected on the surface, 
as expected (Fig. 8). Abs against CT153 were not immunoreactive suggesting that 
CT153 was not surface-accessible. However, CT153 was present in much smaller 
quantities in EBs when compared to MOMP (Fig. 7). This quantity could fall below the 
limits o f detection for immunodot blot, but CT153 could still function in initial host cell 
interactions. Neutralization o f  infectivity assays were performed to determine if  CT153 
functions in host cell invasion (Caldwell and Perry, 1982). Anti-CT153 Abs failed to 
block the attachment and entry o f EBs into host cells (data not shown). These results 
suggest CT153 is not surface-exposed on the EB and is not necessary for host cell 
invasion, but is important during intracellular growth. However, it does not rule out that 
CT153 could function during entry, but is present on the surface in a form not accessible 
to Abs.
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Figure 8. CT153 is not surface-
exposed. Purified C. trachom atis  EBs 
were dotted to nitrocellulose and probed 
with anti-CT153 Abs and control Abs 
against a cytosolic protein (Hsp60), 
surface antigens (MOMP, LPS), and pre- 
immune sera. In contrast to MOMP and 
LPS, CT153 was sim ilar to Hsp60 and 
not accessible to Abs. Reciprocal Ab 
dilutions are listed across the top, and 
Abs are shown to the left.
2.4.4 CT153 is expressed mid-developmental cycle and processed to 59 kDa and 42 kDa 
polypeptides.
Temporal Western blot analysis o f  C. trachomatis infected cells was performed to 
examine the kinetics o f  CT153 expression (Fig. 9). Anti-MOMP and anti-GAPDH Abs 
were used as chlamydial and cellular controls, respectively. MOMP expression was first 
detected by mid-developmental cycle (24 h), and GAPDH levels remained steady at all 
time points examined. Anti-CT153 Abs detected a 91 kDa polypeptide, which
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corresponds to full length CT153, by 24 h post infection and the am ount o f  protein 
increased until the end o f  the developm ental cycle (60 h). This data is consistent with 
transcriptional analysis show ing that c tl5 3  m RN A  is expressed by  8 h  post infection, 
peaks by  24 h post infection and rem ains elevated for the rem ainder o f  the cycle (Belland 
et al., 2003). Tw o low er m olecular w eight im m unoreactive polypeptides o f  59 kD a and 
42 kD a w ere detected during the sam e tim e periods. Interestingly, the com bined m ass o f  
these sm aller polypeptides was sim ilar to the m ature 91 kD a CT153. A s previously 
shown (Fig. 6) im m unoreactive polypeptides o f  corresponding sizes w ere detected in 
IM AC eluates follow ing purification o f  rCT153 from E. coli and w ere identified by 
M ALD I-TOF m ass spectrom etry as CT153. W e w ere not able to identify the peptides 
from  the kinetic infection studies because o f  lim ited protein am ounts. The findings 
suggest how ever that CT153 is autocatalytic, and the specific processing o f  the protein 
might be critical to it function in the pathogenesis o f  chlam ydial infection.
Figure 9. CT153 is expressed mid-
developm ental cycle and processed to  
59 kDa and 42 kDa polypeptides. C. 
trachomatis infected HeLa 229 cells were 
harvested at the tim es indicated and cell 
lysates w ere separated by SDS-PAGE, 
blotted to nitrocellulose and probed with 
Abs against CT153, MOMP or GAPDH. 
The presence of polypeptides at 59 kDa 
and 42 kDa in equim olar ratios at later 
tim e points indicated processed form s of 
CT153. U; uninfected.
2.4.5 Solubility o fC T 153 .
CT153 expression was further analyzed in purified organism s and by cellular 
fractionation o f  C. trachom atis infected cells (Fig. 10). C oom assie-stained SDS-PA G E 
gels showed that equivalent protein concentrations o f  highly purified EBs and RBs were 
loaded onto gels (Fig. 10A). Positive controls M OM P and Hsp60 were im m uno reactive 
by W estern blot at 40 kDa and 60 kDa, respectively, in EBs and RBs as expected (Fig. 
10B). Intact CT153 w as detected in both developm ental form s using anti-CT153 Abs, 
which is consistent w ith our pervious data (Fig. 7B). RBs contained low quantities o f  
p59, and p42 was not detected in either developm ental form  (Fig. 10B). T hese results 
suggest that p59 associates w ith RBs and that the p59 and the p42 processed form s o f
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Figure 10. Solubility of CT153. C. trachom atis  EBs 
and RBs were prepared for (A) SDS-PAGE and 
Coomassie-stained or (B) immunoblotted w ith CT153 
Abs. The full length (p91) and low levels o f the p59 
were detected. MOMP and Hsp60 were used as 
controls. W estern blots o f (C) insoluble and (D) 
soluble fractions of C. trachom atis  infected L929 cells 
at various h post infection were probed with anti- 
CT 153 Abs. p91, p59 and p42 remain in insoluble 
fractions. p91 was also detected in soluble fractions 
at sim ilar time points. Monoclonal Abs against MOMP 
and CPAF were used for positive controls.
CT153 do not co-purify w ith EBs. 
However, the processed forms 
could be lost from  organism s 
during the purification process, 
w hich involves sonication and 
passage over a density gradient.
C. trachom atis infected 
cells w ere harvested at various 
hours post infection, lysed by 
dounce hom ogenization and 
ultracentrifuged to obtain soluble 
and insoluble fractions. The 
cellular fractions w ere analyzed 
w ith anti-CT 153 Abs, and anti- 
M O M P and CPAF Abs w ere used 
as positive controls for insoluble 
and soluble chlam ydial proteins, 
respectively (Fig. 10C and D). 
M OM P was detected by  m id- 
developm ental cycle exclusively in 
the insoluble fractions (Fig. 10C), 
and CPA F, a w ell-characterized 
secreted protein, w as in the 
insoluble and soluble fractions 
(Fig. 10C and D), as expected.
Consistent w ith the previous kinetic study (Fig. 9), full length CT153 was present 
beginning at 24 h  post infection in both the insoluble and soluble fractions, but was m ost 
abundant in the insoluble fractions (Fig. 10C and D). T he cell wall o f  RBs is fragile 
(Tam ura et al., 1971), and organism s tightly  associated w ith the inclusion m em brane 
could be m ore susceptible to the effects o f  physical perturbation and lyse during the 
hom ogenization process, thereby releasing CT153 into the soluble fraction. The p59 and
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p42 were detected in the insoluble fractions at sim ilar tim e points (Fig. IOC). A n -7 5  
kD a polypeptide was detected in the insoluble fractions by the anti-CT153 Ab, and a 
w eakly reactive band o f  a sim ilar size was detected serovar D infected HeLa cells (Fig. 
9). The use o f  L929 cells infected w ith serovar L2 in these experim ents, com pared to 
serovar D infected H eLa cells in Figure 9 could account for the presence o f  this 
additional polypeptide. Taken together, these data suggest that intact and processed 
form s o f  CT153 associate w ith RBs and support our hypothesis that CT153 interacts with 
mem branes.
2.4.6 Expression o f  CT153-GFP in eukaryotic cells.
Insights regarding the potential function o f  CT153 could be gleaned b y  exam ining 
the subcellular tropism  inside eukaryotic cells. T ransient transfections w ere perform ed to 
characterize the effects o f  CT153 expression in HeLa 229 cells (Fig. 11). T he FuGENE6 
transfection reagent was not toxic to HeLa cells in these experim ents (Fig. 11 A). Positive 
controls em ployed a L A M Pl-m G FP-expressing plasm id, w hich is a w ell-characterized 
m arker o f  late endosom es and lysosom es (D recktrah et al., 2008; Falcon-Perez et al., 
2005), to control for transform ation efficiency. The transform ation efficiency under 
these conditions was -5 0 % . C onsistent w ith previous reports, the L A M Pl-m G FP fusion 
protein exhibited a typical localization pattern o f  brightly  fluorescing vesicular structures 
accum ulated in the perinuclear region o f  the cell (Fig. 11B, arrowheads). Curiously, 
fluorescence was not detected in HeLa cells transfected w ith either C A T-G FP or CT153- 
GFP at any tim e point from  4 h  to 72 h  post transfection (Fig. 11C and D and data not 
shown). The cycle 3 m utant o f  GFP has a prim ary and secondary excitation peak at 395 
nm and 478 nm, respectively, and fluorescence w as not detected using filters specific for 
either o f  these w avelengths (Fig. 11C and D and data not shown). Careful attem pts to 
optim ize the transfection variables w ere considered and included the use o f  tw o different 
transfection reagents— FuG EN E 6 o r FuG EN E HD. U tilizing either one of these 
reagents the following variables w ere tested: cell passage num ber, confluency o f  the cell 
m onolayers, m edia:reagent or reagent:D N A  incubation tim es, reagent:D N A  quantities 
used for transfection com plex form ation, volum e o f  transfection com plex added to 
m onolayers and incubation tim e post transfection. Specific GFP fluorescence above
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background w as not detected for CAT-G FP or CT153-G FP (Fig. 11, com pare C and D to 
A) under any o f  these conditions despite careful m onitoring o f  the cells. A nti-GFP or 
anti-CT153 Abs did not detect CT153-G FP in w estern blots o f  transfected cells at 24 h, 
48 h, o r 72 h follow ing transfection (data not shown). Given that DNA sequencing 
confirm ed the integrity o f  the plasm id, the absence o f  CT153-G FP fluorescence points to 
either low transform ation efficiency o f  the plasm id o r a lack o f  CT153-G FP expression in 
the HeLa cell line. These studies could be extended to test the efficiency o f  other cell 
lines and transfection reagents (Lipofectam ine from  Invitrogen or Effectene from  Qiagen) 
or m ore classic protocols such as transfection by  calcium  phosphate (G raham  and van der 
Eb, 1973). Further, the c tl5 3  allele could be cloned into different m am m alian expression 
vectors that would express CT153 fused to a fluorescent protein other than the cycle 3 
m utant o f  GFP or a tag such as the V5 epitope.
reagent LAMP1-mGFP CAT-GFP CT153-GFP
Figure 11. Expression of CT153-GFP in eukaryotic cells. HeLa cells were transiently 
transfected w ith (A) reagent alone or plasm ids encoding either (B) LAMP1-mGFP, (C) CAT- 
GFP or (D) CT153-GFP and visualized at 48 h post transfection. Representative fie lds for 
each plasmid is shown. Only LAM P1-m GFP exhibited effic ient transfection rates and intense 
fluorescent signal. Transfected cells are indicated (arrowhead). The top panel shows the 
GFP fluorescence in grayscale. Overlays are shown in the bottom panel.____________________
2.4.7 CT153 localizes to a subset o f  typical and large atypical RBs that have a polar 
distribution in juxtaposition to the host nucleus.
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C. trachomatis infected cells were fixed and permeabilized at different times post 
infection, immunolabeled with anti-CT153 or anti-Hsp60 and anti-MOMP Abs, and 
analyzed by confocal microscopy. MOMP, which is an abundant outer membrane 
protein found on both EBs and RBs, uniformly stained all chlamydial developmental 
forms contained in the inclusion (Fig. 12A and B). In contrast, the pattern o f  CT153 
labeling was quite distinct from that o f MOMP. CT153 staining was not distributed 
throughout the inclusion but localized to a subpopulation o f what appeared to be mature 
RBs (Fig. 12A, arrows and arrow heads) and less abundant but very large RB like 
particles (Fig. 12A, asterisk). These immunoreactive RB forms were commonly found 
lining the inner leaflet o f  the inclusion membrane (Fig. 12A, arrows) and polarized to
1
anti-M OM P anti-CT153 overlay
anti-M OM P anti-Hsp60 overlay
Figure 12. CT153 localizes to a subset of typical and large atypical RBs that have a 
polar distribution juxtapositioned to  the host nucleus. C. trachom atis  infected HeLa 
cells were fixed late in the developm ental cycle and were immunolabeled w ith (A) anti-CT153 
or (B) anti-Hsp60 and anti-M OMP Abs. (A) CT153 (green) localized to RBs lining the 
inclusion mem brane (arrows) and in juxtanuclear regions o f the inclusion (arrow  heads) and 
to large RB-like structures (asterisks). (B) Hsp60 labeled RBs adjacent to the inclusion 
membrane (arrows) and larger RBs (asterisks). The immunolabeling patterns fo r CT153 and 
Hsp60 are similar. MOMP is labeled red, and DNA is stained blue. N; host cell nucleus. A 
single confocal section is shown.
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juxtanuclear regions w ithin the inclusion (Fig. 12A, arrow heads). A clear distinction 
betw een cytosolic and outer m em brane localization o f  CT153 was not discernible at this 
level o f  resolution. This staining pattern w as strikingly sim ilar to w hat w e have recently 
described for the pzPLD , CT155 (Nelson et al., 2006), supporting a hypothesis that 
CT153 and the pzPLD s m ight be functionally related. Interestingly, Hsp60 staining was 
rem arkably sim ilar to CT153 (Fig. 12B). Hsp60 localized to RB developm ental form s 
positioned at the lum inal face o f  the inclusion (Fig. 12B, arrow s) and to the large RB-like 
particles (Fig. 12B, asterisk). Sim ilar staining patterns for Hsp60 have been previously 
described (Bannantine et a l ., 2000; Beatty et al., 1993; H euer et al., 2009).
2.4.8 CT153 localizes to a subpopulation o f  RBs.
W e perform ed im m unoelectron m icroscopy on C. trachom atis infected cells to 
m ore precisely localize CT153 in chlam ydial developm ental forms. A nti-M O M P and 
anti-H sp60 Abs w ere used as controls for chlam ydial outer m em brane and cytosolic 
staining, respectively. M OM P exhibited strong outer m em brane staining on all EBs and 
RBs throughout the inclusion (Fig. 13, right panel). In contrast to M O M P, CT153 
im m unoreactivity was restricted to the cytosol o f  a subpopulation o f  RBs and to very 
large RBs adjacent to the inner leaflet o f  the inclusion m em brane in jux taposition  to the 
nucleus (Fig. 13, left panel). Hsp60 staining w as rem arkably sim ilar to CT153 and was 
detected in the cytosol o f  a restricted population o f  RBs (Fig. 13, m iddle panel). The 
staining patterns detected for CT153, Hsp60 and M OM P by TEM  are consistent w ith the 
localization o f  these proteins observed by confocal m icroscopy (Fig. 12). These data are 
the first to show that CT153 and Hsp60 are predom inant w ithin a specific subpopulation 
o f  RBs that are positioned at the inclusion m em brane. The RB staining w as m ost 
pronounced in m id to late cycle o f  infection, and the very large RB particles w ere m ost 
often observed during late infection in m ature inclusions. W e believe that this unique 
and intriguing RB staining characteristic in not an artifact o f  fixation or staining for the 
follow ing reasons, (i) identical staining patterns w ere observed in m ethanol fixed cells 
(data not shown), and (ii) the staining pattern has been observed independently  for Hsp60 
and CT155 by m ultiple investigators (Bannantine et al., 2000; Beatty et al., 1993; Heuer 
e t al., 2009; N elson et al., 2006).
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an ti-C T153 an ti-H sp60 anti-M O M P
Figure 13: CT153 localizes to a subpopulation of RBs. C. trachomatis infected HeLa 
cells were fixed late in the developm ental cycle, immunolabeled with anti-CT153, anti- 
MOMP or anti-Hsp60 and prepared for TEM. CT153-positive RBs were found primarily at 
the RB-inclusion membrane interface (arrows). Hsp60 stained a sim ilar population o f RBs. 
MOMP stained the outer membrane of EBs, RBs and large RBs that are observed in mature 
inclusions. Scale bar, 2 pm. ___________________________________________
2.4.9 M ultivesicular body inhibitors perturb chlam ydial developm ent.
Interactions betw een chlam ydial inclusions and M VBs are essential for C. 
trachomatis developm ent and replication (Beatty, 2006). In vitro  M VB inhibition assays 
were perform ed in cells infected w ith either C. trachom atis (CT 153-positive) o r C. caviae 
(C T 153-negative) to determ ine the effect on chlam ydial growth. In the presence o f  3- 
M eA, a potent inhibitor o f  M VB m aturation, the developm ent o f  C. trachom atis and C. 
caviae was severely disrupted (Fig. 14). In the presence o f  3-M eA both strains exhibited 
a reduction in the recoverable infection form ing units yield (Fig. 14A), and the inclusion 
size was m arkedly reduced (Fig. 14B). The results for C. trachom atis are consistent with 
a previous study (Beatty, 2006). These data indicate that norm al M VB m aturation is 
necessary for the grow th o f  both strains and suggests that M VB fusion is not unique to C. 
trachomatis. Since both strains require norm al M VB m aturation for survival it is 
unlikely CT153 functions to m ediate this interaction.
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Figure 14: Replication and growth of C. trachom atis  and C. caviae  in the presence of a 
MVB inhibitor. C. trachom atis- or C. caw'ae-infected HeLa cells were treated with 3-MeA 1 h 
after infection. Late during infection A) recoverable infection form ing units were determ ined 
and B) cells were immunolabeled with MO M P-specific Abs. Recovery of infectious C. 
trachomatis  and C. caviae  organism s was decreased in the presence of 3-MeA. 
Immunofluorescence m icroscopy shows that inclusion size and number was significantly 
reduced in the presence o f a MVB inhibitor.
2.4.10 Lipid droplets localize inside C. trachom atis  inclusions adjacent to large atypical 
RBs.
Neutral lipid-rich LD hom eostasis is disrupted in C. trachom atis infected cells 
and host cytoplasm ic LDs translocate to the lum en o f  the inclusion during infection 
(Cocchiaro et al., 2008; K um ar et al., 2006). LDs represent a potentially  unique source 
o f  host-derived lipids for C. trachom atis, and w e hypothesized that CT153 and the 
pzPLDs could facilitate these interactions. W e used a neutral lipid-specific fluorescent 
dye, BO D IPY 495/503, to com pare LD distribution in C. trachom atis (CT153-postive) 
and C. caviae  (CT 153-negative) infected cells late during infection by  confocal 
microscopy. The LD staining patterns betw een C T 153-positive and CT 153-negative 
strains w ere m arkedly different (Fig. 15). In C. trachom atis  infected cells LDs w ere 
redistributed in the host cytosol and w ere detected inside inclusions (Fig. 15A), consistent 
w ith previous reports (Cocchiaro et al., 2008; K um ar et al., 2006). Interestingly, two 
large RBs w ere im m ediately adjacent to an inclusion-sequestered LD. In contrast to C. 
trachom atis, the neutral lipid staining was weak and dispersed w ith no prom inent 
structures inside C. caviae  inclusions (Fig. 15B). The presence o f  intra-inclusion LDs 
correlates w ith retention o f  CT153 and pzPLD s in the genom e. T hese data suggest that 
CT153, pzPLDs and the intra-inclusion LDs m ay be involved w ith C. trachom atis-
□  C. trachom atis
□  C. ca v ia e
C. trachomatis
C. caviae
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specific aspects o f lipid metabolism or acquisition and could represent unique virulence 
factors that are important to the pathogenesis o f human infection and disease.
C. trachomatis
C. caviae
BODIPY DNA overlay
Figure 15. Lipid droplets localize inside C. trachom atis  inclusions adjacent to large 
RBs. C. trachom atis  and C. caviae infected HeLa cells were labeled with BODIPY 495/503 
to compare neutral lipid distribution. C. trachom atis  inclusions contained large intra­
inclusion LDs (arrowhead; top panel) adjacent to large RB like structures (arrows, top 
panel). Neutral lipid staining was weak and dispersed in C. caviae  inclusions (bottom 
panel). The white dotted line represents the boundary o f the inclusion. DNA is labeled blue. 
N; host cell nucleus.
2.5 Discussion
Genomic variability in Chlamydia is clustered to the PZ, which encodes strain- 
and species-variable genes that are key mediators o f chlamydial pathogenic diversity. 
Here we provide the first description o f  the PZ MACPF domain containing protein and 
show that CT153 is a highly conserved C. trachomatis specific protein present in all 15 
human serovariants. CT153 is expressed mid-developmental cycle and undergoes 
proteolytic processing to forms that associate primarily with RBs. The immunostaining 
patterns for CT153 and the chaperone, Hsp60, are strikingly similar to the pzPLD CT155 
(Nelson et al., 2006) and are localized to a subset o f  RBs in contact with the inclusion 
membrane and to larger atypical RBs adjacent to intra-inclusion LDs. These data suggest
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CT153 plays an im portant C. trachom atis specific role in m em brane m odification or lipid 
acquisition.
Biochem ical studies and genom ic sequence analysis indicate that C hlam ydia  have 
undergone reductive genom ic evolution and are dependent on the host cell for m etabolic 
interm ediates including lipids, ribonucleotides, and am ino acids (M cClarty, 1999). 
However, chlam ydiae cannot freely access the nutrient-rich cytosol as the inclusion 
m em brane is im perm eable to m olecules >520 Da (H einzen and H ackstadt, 1997). 
Because o f  this niche Chlamydia  have m ost likely evolved strategies to com pete w ith the 
host for access to m etabolite pools (M oulder, 1974). O ne w ay for an organism  to gain a 
fitness advantage over a com peting species is to d istribute the burden o f  acquiring 
m etabolic interm ediates to a subset o f  cells. For exam ple, Bacillus and Pseudom onas 
form genetically clonal colonies in w hich a “division o f  labor” exists am ong subsets o f  
cells that perform  specialized functions for the benefit o f  the entire population (Kearns, 
2008). O ur data raises the possibility  that a sim ilar scenario exists for Chlamydia. RBs 
intim ately associated w ith the inclusion m em brane are uniquely positioned for direct 
interactions w ith the host cell and could facilitate nutrient uptake or respond to 
m icroenvironm ental cues from the eukaryotic cytosol. O ur data show s that a 
subpopulation o f  RBs in late inclusions expresses M OM P, CT153 and H sp60 (Figs. 12 
and 13); at least one pzPLD displays a sim ilar staining pattern (Nelson et al., 2006). In 
E. coli Hsp60 is a chaperonin associated w ith stress response and norm al processes o f 
grow th and replication that requires protein folding to occur w ith high fidelity (E llis and 
van der V ies; 1991). Increased Hsp60 expression is associated w ith chlam ydial response 
to physiological stress (B eatty  et a l ., 1994; Raulston, 1997). By m id-developm ental 
cycle the size o f  the inclusion expands and RBs enter logarithm ic growth. O ur data 
suggests that RBs tightly  associated w ith the inclusion m em brane are “hyper” m etabolic 
as they acquire nutrients from the host and undergo rapid growth. B ecause CT153 
contains m em brane interacting m otifs and pzPLD s are putative lipid hydrolyzing 
enzym es, w e propose that CT153 and the pzPLD s share a concom itant function w ithin 
this subset o f  RBs to actively m odify m em branes or lipids acquired from  the host.
Lipid profiling o f  purified organism s (W ylie et al., 1997), lipid trafficking studies 
(Carabeo et al., 2003; Hackstadt et al., 1996; Hackstadt et al., 1995) and genom ic
analysis (Stephens e t al., 1998) indicate Chlamydia  are capable o f  lim ited lipid synthesis. 
However, clear hom ologs o f  biosynthetic enzym es necessary for anabolism  o f  m any 
classes o f  m em brane lipids are m issing from  the genom e indicating that Chlamydia  
obtains them  from host cells. Host-derived glycerophospholipids are trafficked to the 
inclusion, and the sn-2  fatty acid tail is cleaved by host cytoplasm ic phospholipase A, 
w hich is reacylated w ith a Chlam ydia-synthesized branched chain fatty acid (Su et al., 
2004; W ylie et al., 1997). C. trachomatis translocates cytoplasm ic LDs into the lum en o f 
inclusions (Cocchiaro et al., 2008). The C. trachom atis inclusion fuses w ith M V Bs to 
acquire lysobisphosphatidic acid (Beatty, 2006) and G olgi-derived exocytic vesicles to 
incorporate sphingom yelin and cholesterol (Carabeo et al., 2003; Hackstadt et al., 1996; 
Hackstadt et al., 1995). It is not clear how  m em brane lipids are transported across the 
inclusion m em brane or how Chlamydia  assim ilates lipids from  host-derived sources. It is 
possible that Chlamydia  parasitize nutrients from the host cell by  one pathw ay early  in 
infection when dem ands for physiological m etabolites from  the host are low. Then, as 
the num ber o f  organism s increases and pressures on host cell resources are greater, 
Chlamydia  m ay deploy additional strategies to acquire sufficient quantities o f  nutrients 
from the host. For example, Chlamydia  acquires sphingolipids from  the Golgi w ithin the 
first 4 h following infection (H ackstadt et al., 1996). D uring logarithm ic grow th C. 
trachom atis induces Golgi fragm entation, w hich enhances the transport o f  sphingolipids 
to the inclusion to support the grow ing num bers o f  chlam ydial progeny (H euer et al., 
2009). Sim ilarly, LDs initially interact transiently w ith the inclusion m em brane until the 
later stages o f  infection w hen m ore stable contacts are established (Cocchiaro et al., 
2008) possibly reflecting an increase in chlam ydial dem and for host lipids.
Listeria  and Rickettsia  express M ACPF dom ain containing proteins and 
phospholipases as virulence factors to m odify host m em branes. The bacterial 
phospholipases and either listeriolysin O, w hich is structurally hom ologous to the 
M ACPF dom ain, or rickettsial T lyC , a M ACPF dom ain containing hem olysin are 
required for escape from  the nascent phagolysosom e follow ing host cell entry (Cossart et 
al., 1989; Smith et al., 1995; W hitw orth et al., 2005). A M A CPF dom ain in CT153 
suggests the protein is involved w ith m em brane m odification or destabilization. pzPLDs 
are critical to C. trachom atis survival late in the developm ental cycle (N elson et al.,
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2006). We hypothesize that C. trachomatis utilizes CT153 and the pzPLDs to mediate 
strain-specific transportation or modification o f incoming membrane and lipids from the 
host. We favor a model in which CT153 and the pzPLDs function in a specific 
interaction with host cells over a more generalized role in membrane fusion events 
between Chlamydia and the host because both C. trachomatis (CT 153-positive) and C. 
caviae (CT-153 negative) are sensitive to the effects o f  MVB maturation inhibition by 3- 
MeA (Fig. 14).
Recent reports suggest two interactions with the host cell in which CT153 and the 
pzPLDs could potentially function (Cocchiaro et al., 2008; Heuer et al., 2009). 
Chlamydial growth and inclusion expansion that occurs mid-developmental cycle is 
dependent upon Golgi fragmentation. The Golgi ministacks decorate the cytoplasmic 
face o f  the inclusion membrane adjacent to Hsp60 expressing RBs (Heuer et al., 2009), 
and Chlamydia acquires Golgi-derived sphingomyelin and cholesterol (Carabeo et al., 
2003; Hackstadt et al., 1996; Hackstadt et al., 1995). LDs, which are dynamic organelles 
that play a central role in managing membrane lipids in eukaryotic cells (Zehmer et al., 
2009), are translocated to the lumen o f  mature C. trachomatis inclusions and are 
apparently consumed by RBs after 30 h post infection (Cocchiaro et al., 2008). 
Interestingly, our data shows that the kinetics o f  CT153 expression, proteolytic 
processing (Fig. 9 and 10) and localization (Fig. 12 and 13) correlates temporally with the 
formation o f  Golgi ministacks and translocation o f  LD from the cytosol into the 
chlamydial inclusion. CT153 was detected as early as 8 h post infection in RBs (data not 
shown), and as the developmental cycle progressed CT153 immunolabeling became 
distinct from MOMP and was limited to a subset o f RBs (Figs. 12 and 13 and data not 
shown). At late time points (36 h post infection) CT153 redistribution was more 
pronounced and localized to a subpopulation o f large atypical RBs and RBs in contact 
with the inclusion membrane and in juxtanuclear regions o f the inclusion (Figs. 12 and 
13). Our results show that late in infection morphologically distinct RBs express CT153, 
Hsp60 and a pzPLD (Fig. 12 and 13; Nelson et al., 2006) suggesting a specialized 
function within these organisms. The redistribution o f  CT153 staining to a subpopulation 
o f RBs by ~24 h post infection coincides temporally with Chlamydia-induced Golgi 
fragmentation (Heuer et al., 2009). This subset o f RBs in juxtaposition to the inner
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leaflet o f  the inclusion m em brane would be optim ally positioned to intercept vesicles 
from Golgi m inistacks clustered at the cytoplasm ic face o f  the inclusion m em brane. LDs 
contain over 160 lipid species and are com posed o f  a neutral lipid-rich core surrounded 
by a phospholipid m onolayer enriched w ith phosphatidylcholine (Bartz et al., 2007). 
Classically, PLDs hydrolyze the phosphodiester bond o f  phosphatidylcholine and the 
pzPLD, CT156/Lda-1, colocalizes w ith LDs gathered at the cytoplasm ic surface o f  the 
inclusion m em brane (K um ar et al., 2006). As LDs enter the inclusion m em branous blebs 
and vesicles are apparent (Cocchiaro et al., 2008) indicating that the m em branes o f  RBs, 
the inclusion or LDs are actively disrupted o r m odified. The data presented here indicate 
that RBs expressing CT153, Hsp60 and a pzPLD (Fig. 12 and 13; N elson et al., 2006) are 
in direct contact w ith intra-inclusion LDs (Fig. 15). This is consistent w ith data showing 
that RBs positioned on the inner leaflet o f  the inclusion m em brane establish a tight 
interaction w ith incom ing LDs (Cocchiaro et al., 2008). U nfortunately, we w ere unable 
to establish a direct link betw een CT 153-positive RBs and intra-inclusion LDs by 
im m unofluorescence m icroscopy as these organelles are sensitive to the am ount o f 
detergent needed to perm eabilize and im m unolabel cells w ith anti-CT153 Abs (data not 
shown; Ohsaki et al., 2005). Taken together, these studies suggest a role for CT153 and 
the pzPLDs in the uptake and consum ption o f  lipids from G olgi-derived vesicles or intra­
inclusion LDs.
The studies presented here provide the first characterization o f  CT153 during 
intracellular growth and confirm  the expression o f  the protein in all C. trachom atis 
serovars im plicating an im portant role for the protein in chlam ydial pathogenesis. W e 
have found that CT153 and Hsp60 are localized to a distinct subpopulation o f  RBs 
suggesting a “redistribution o f  labor” during the late stages o f  the developm ental cycle. 
Based on these data w e propose a m odel in w hich CT153 is activated by proteolytic 
processing and shares a concom itant function w ith the pzPLD s w ithin a specialized 
subpopulation o f  RBs that are involved in the acquisition o f  host-derived lipids in C. 
trachom atis infections. Elucidating the nature o f  the interaction betw een CT153 and 
m em bers o f  the pzPLD fam ily will be im portant to understanding the role o f  these 
proteins in chlam ydial pathogenesis and is the focus o f  further investigation. The activity 
o f  pzPLD s w as essential for recovery o f  C. trachom atis from  an interferon-y induced
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persistent state (Nelson et al., 2006). It will be o f interest to determine the role o f CT153 
in this important aspect o f  chlamydial pathogenesis.
2.6 Acknowledgements
We would like to thank Dr. Gaungming Zhong for the kind gift o f  anti-CPAF 
antibodies, Seth Winfree for sharing the LA M Pl-m G FP plasmid and protocols, and Kelly 
Matteson and Anita Mora for editorial and graphical assistance. This research was 
supported by the Intramural Research Program o f the NIH, NIAID.
2.7 References
Azuma, Y., H. Hirakawa, A. Yamashita, Y. Cai, M. A. Rahman, H. Suzuki, S. 
Mitaku, H. Toh, S. Goto, T. M urakami, K. Sugi, H. Hayashi, H. Fukushi, M. 
Hattori, S. Kuhara, and M. Shirai. 2006. Genome sequence o f the cat pathogen, 
Chlamydophila felis. DNA Res. 13:15-23.
Bannantine, J. P., R. S. Griffiths, W. Viratyosin, W. J. Brown and D. D. Rockey. 
2000. A secondary structure m otif predictive o f  protein localization to the 
chlamydial inclusion membrane. Cell. Micriobiol. 2:35-47.
Bartz, R., W. H. Li, B. Venables, J. K. Zehmer, M. R. Roth, R. W elti, R. G. 
Anderson, P. Liu, and K. D. Chapman. 2007. Lipidomics reveals that 
adiposomes store ether lipids and mediate phospholipid traffic. J. Lipid Res. 
48:837-847.
Beatty, W. L. 2006. Trafficking from CD63-positive late endocytic m ultivesicular bodies 
is essential for intracellular development o f  Chlamydia trachomatis. J. Cell Sci. 
119:350-359.
Beatty, W. L., G. I. Byrne, and R. P. M orrison. 1993. Morphologic and antigenic 
characterization o f  interferon gamma-mediated persistent Chlamydia trachomatis 
infection in vitro. Proc. Natl. Acad. Sci. U S A  90:3998-4002.
52
Beatty, W . L., R. P. M orrison, and G. I. Byrne. 1994. Immunoelectron-microscopic 
quantitation o f  differential levels o f chlamydial proteins in a cell culture model o f 
persistent Chlamydia trachomatis infection. Infect. Immun. 62:4059-4062.
Belland, R. J., M. A. Scidmore, D. D. Crane, D. M. Hogan, W. W hitmire, G. 
McCIarty, and H. D. Caldwell. 2001. Chlamydia trachomatis cytotoxicity 
associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. U S 
A 98:13984-13989.
Belland, R. J., G. Zhong, D. D. Crane, D. Hogan, D. Sturdevant, J. Sharma, W. L. 
Beatty, and H. D. Caldwell. 2003. Genomic transcriptional profiling o f the 
developmental cycle o f  Chlamydia trachomatis. Proc. Natl. Acad. Sci. U S A 
100:8478-8483.
Caldwell, H. D., J. Kromhout, and J. Schachter. 1981. Purification and partial 
characterization o f  the major outer membrane protein o f  Chlamydia trachomatis. 
Infect. Immun. 31:1161-1176.
Caldwell, H. D., C. C. Kuo, and G. E. Kenny. 1975. Antigenic analysis o f  Chlamydiae 
by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between
C. trachomatis and C. psittaci. J. Immunol. 115:963-968.
Caldwell, H. D., and L. J. Perry. 1982. Neutralization o f  Chlamydia trachomatis 
infectivity with antibodies to the major outer membrane protein. Infect. Immun. 
38:745-754.
Caldwell, H. D., H. W ood, D. Crane, R. Bailey, R. B. Jones, D. M abey, I. Maclean, 
Z. M ohammed, R. Peeling, C. Roshick, J. Schachter, A. W. Solomon, W. E. 
Stamm, R. J. Suchland, L. Taylor, S. K. W est, T. C. Quinn, R. J. Belland, 
and G. McCIarty. 2003. Polymorphisms in Chlamydia trachomatis tryptophan 
synthase genes differentiate between genital and ocular isolates. J. Clin. Invest. 
111:1757-1769.
Carabeo, R. A., D. J. Mead, and T. Hackstadt. 2003. Golgi-dependent transport of 
cholesterol to the Chlamydia trachomatis inclusion. Proc. Natl. Acad. Sci. U S A  
100:6771-6776.
Carlson, J. H., S. Hughes, D. Hogan, G. Cieplak, D. E. Sturdevant, G. McCIarty, H.
D. Caldwell, and R. J. Belland. 2004. Polymorphisms in the Chlamydia
53
trachomatis cytotoxin locus associated with ocular and genital isolates. Infect. 
Immun. 72:7063-7072.
Carlson, J. H., S. F. Porcella, G. M cClarty, and H. D. Caldwell. 2005. Comparative 
genomic analysis o f  Chlamydia trachomatis oculotropic and genitotropic strains. 
Infect. Immun. 73:6407-6418.
Cocchiaro, J. L., Y. Kumar, E. R. Fischer, T. Hackstadt, and R. H. Valdivia. 2008. 
Cytoplasmic lipid droplets are translocated into the lumen o f the Chlamydia 
trachomatis parasitophorous vacuole. Proc. Natl. Acad. Sci. U S A  105:9379- 
9384.
Cossart, P., M. F. Vicente, J. M engaud, F. Baquero, J. C. Perez-Diaz, and P. Berche. 
1989. Listeriolysin O is essential for virulence o f  Listeria monocytogenes: direct 
evidence obtained by gene complementation. Infect. Immun. 57:3629-3636.
Crane, D. D., J. H. Carlson, E. R. Fischer, P. Bavoil, R. C. Hsia, C. Tan, C. C. Kuo, 
and H. D. Caldwell. 2006. Chlamydia trachomatis polymorphic membrane 
protein D is a species-common pan-neutralizing antigen. Proc. Natl. Acad. Sci. U 
S A 103:1894-1899.
Dong, F., J. Sharma, Y. Xiao, Y. Zhong, and G. Zhong. 2004. Intramolecular 
dimerization is required for the chlamydia-secreted protease CPAF to degrade 
host transcriptional factors. Infect. Immun. 72:3869-3875.
Drecktrah, D., S. Levine-W ilkinson, T. Dam, S. W infree, L. A. Knodler, T. A. 
Schroer, and O. Steele-M ortimer. 2008. Dynamic behavior o f Salmonella- 
induced membrane tubules in epithelial cells. Traffic 9:2117-2129.
Ellis, R. J., and S. M. van der Vies. 1991. M olecular chaperones. Annu. Rev. Biochem. 
60:321-347.
Falcon-Perez, J. M., R. Nazarian, C. Sabatti, and E. C. Dell’Angelica. 2005. 
Distribution and dynamics o f  Lamp 1-containing endocytic organelles in 
fibroblasts deficient in BLOC-3. J. Cell Sci. 118:5243-5255.
Fan, T., H. Lu, H. Hu, L. Shi, G. A. M cClarty, D. M. Nance, A. H. Greenberg, and 
G. Zhong. 1998. Inhibition o f  apoptosis in Chlamydia-infected cells: blockade of 
mitochondrial cytochrome c release and caspase activation. J. Exp. Med. 187:487- 
496.
54
Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay o f infectivity 
o f human adenovirus 5 DNA. Virology 52:456-467.
Hackstadt, T., D. D. Rockey, R. A. Heinzen, and M. A. Scidmore. 1996. Chlamydia 
trachomatis interrupts an exocytic pathway to acquire endogenously synthesized 
sphingomyelin in transit from the Golgi apparatus to the plasma membrane. 
EMBO J. 15:964-977.
Hackstadt, T., M. A. Scidmore, and D. D. Rockey. 1995. Lipid metabolism in 
Chlamydia trachomatis-infected cells: directed trafficking o f  Golgi-derived 
sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. U S A  92:4877- 
4881.
Hatch, G. M., and G. McClarty. 1998. Phospholipid composition o f  purified Chlamydia 
trachomatis mimics that o f  the eucaryotic host cell. Infect. Immun. 66:3727-3735.
Heinzen, R. A., and T. Hackstadt. 1997. The Chlamydia trachomatis parasitophorous 
vacuolar membrane is not passively permeable to low-molecular-weight 
compounds. Infect. Immun. 65:1088-1094.
Heuer, D., A. R. Lipinski, N. M achuy, A. Karlas, A. W ehrens, F. Siedler, V. 
Brinkmann, and T. F. Meyer. 2009. Chlamydia causes fragmentation o f the 
Golgi compartment to ensure reproduction. Nature 457:731-735.
Ishino, T., Y. Chinzei, and M. Yuda. 2005. A Plasmodium  sporozoite protein with a 
membrane attack complex domain is required for breaching the liver sinusoidal 
cell layer prior to hepatocyte infection. Cell. Microbiol. 7:199-208.
Kadota, K., T. Ishino, T. M atsuyama, Y. Chinzei, and M. Yuda. 2004. Essential role 
o f membrane-attack protein in malarial transmission to mosquito host. Proc. Natl. 
Acad. Sci. U S A  101:16310-16315.
Kafsack, B. F., J. D. Pena, I. Coppens, S. Ravindran, J. C. Boothroyd, and V. B. 
Carruthers. 2009. Rapid membrane disruption by a perforin-like protein 
facilitates parasite exit from host cells. Science 323:530-533.
Kalman, S., W. M itchell, R. Marathe, C. Lammel, J. Fan, R. W. Hyman, L. Olinger, 
J. Grimwood, R. W. Davis, and R. S. Stephens. 1999. Comparative genomes o f 
Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21:385-389.
55
Kari, L., W . M . W hitm ire, J. H. C arlson, D. D. C rane, N. R eveneau, D. E. N elson, D. 
C. M abey, R. L. Bailey, M . J . H olland, G. M cC larty, and H. D. Caldwell. 
2008. Pathogenic diversity  am ong C hlam ydia trachom atis ocular strains in 
nonhum an prim ates is affected b y  subtle genom ic variations. J. Infect. Dis. 
197:449-456.
K earns, D. B. 2008. D ivision o f  labour during Bacillus subtilis  b iofilm  form ation. M ol.
M icrobiol. 67:229-231.
K um ar, Y ., J. C occhiaro, and R. H. V aldivia. 2006. T he obligate in tracellu lar pathogen 
Chlamydia trachom atis targets host lipid droplets. Curr. Biol. 16:1646-1651. 
M cClarty, G. 1999. Chlam ydial m etabolism  as inferred from  the com plete genom e 
sequence, p. 69-100. In  R. S. Stephens (ed.), Chlamydia: in tracellu lar biology, 
pathogenesis, and im m unity. A SM  Press, W ashington, D. C.
M cC larty, G ., H. D. C aldw ell, and D. E. N elson . 2007. Chlam ydial interferon gam m a 
im m une evasion influences infection tropism . Curr. Opin. M icrobiol. 10:47-51. 
M oulder, J. W . 1974. In tracellular parasitism : life in an extrem e environm ent. J. Infect. 
Dis. 130:300-306.
M oulder, J. W . 1991. Interaction o f  C hlam ydiae  and host cells in vitro. M icrobiol. Rev. 
55:143-190.
N elson, D. E ., D. D. C rane, L. D. T aylor, D. W . D orw ard, M . M . G oheen, and H. D. 
C aldw ell. 2006. Inhibition o f  chlam ydiae  by  prim ary alcohols correlates w ith the 
strain-specific com plem ent o f  plasticity  zone phospholipase D genes. Infect. 
Im m un. 74:73-80.
N elson, D. E ., L. D. T aylor, J. G. Shannon, W . M . W hitm ire, D. D. C rane, G. 
M cC larty, H. Su, L. Kari, and H. D. C aldw ell. 2007. Phenotypic rescue o f  
C hlam ydia trachom atis  grow th in IFN -gam m a treated m ouse cells b y  irradiated 
C hlam ydia m uridarum . Cell. M icrobiol. 9 :2289-2298.
N elson, D. E., D. P. V irok, H. W ood, C. R oshick, R. M . Johnson , W . M . W hitm ire, 
D. D. C rane, O. Steele-M ortim er, L. Kari, G. M cC larty, and H. D. Caldw ell. 
2005. C hlam ydial IFN -gam m a im m une evasion is linked to host infection 
tropism . Proc. Natl. Acad. Sci. U S A  102:10658-10663.
56
Ohsaki, Y., T. Maeda, and T. Fujimoto. 2005. Fixation and permeabilization protocol 
is critical for the immunolabeling o f  lipid droplet proteins. Histochem. Cell Biol. 
124:445-452.
Peitsch, M. C., P. Amiguet, R. Guy, J. Brunner, J. V. Maizel, Jr., and J. Tschopp. 
1990. Localization and molecular m odelling o f  the membrane-inserted domain of 
the ninth component o f human complement and perforin. Mol. Immunol. 27:589- 
602.
Ponting, C. P. 1999. Chlamydial homologues o f  the MACPF (MAC/perforin) domain.
Curr. Biol. 9 :R 911-913.
Ponting, C. P., and I. D. Kerr. 1996. A novel family o f  phospholipase D homologues 
that includes phospholipid synthases and putative endonucleases: identification o f 
duplicated repeats and potential active site residues. Protein Sci. 5:914-922. 
Raulston, J. E. 1997. Response o f Chlamydia trachomatis serovar E to iron restriction in 
vitro and evidence for iron-regulated chlamydial proteins. Infect. Immun. 
65:4539-4547.
Read, T. D., R. C. Brunham, C. Shen, S. R. Gill, J. F. Heidelberg, O. W hite, E. K. 
Hickey, J. Peterson, T. Utterback, K. Berry, S. Bass, K. Linher, J. W eidman, 
H. Khouri, B. Craven, C. Bowman, R. Dodson, M. Gwinn, W. Nelson, R. 
DeBoy, J. Kolonay, G. M cClarty, S. L. Salzberg, J. Eisen, and C. M. Fraser. 
2000. Genome sequences o f  Chlamydia trachomatis MoPn and Chlamydia 
pneumoniae AR39. Nucleic Acids Res. 28:1397-1406.
Read, T. D., G. S. Myers, R. C. Brunham, W. C. Nelson, I. T. Paulsen, J. Heidelberg, 
E. Holtzapple, H. Khouri, N. B. Federova, H. A. Carty, L. A. Umayam, D. H. 
Haft, J. Peterson, M. J. Beanan, O. W hite, S. L. Salzberg, R. C. Hsia, G. 
McClarty, R. G. Rank, P. M. Bavoil, and C. M. Fraser. 2003. Genome 
sequence o f Chlamydophila caviae (Chlamydia psittaci GPIC): examining the 
role o f  niche-specific genes in the evolution o f the Chlamydiaceae. Nucleic Acids 
Res. 31:2134-2147.
Rosado, C. J., A. M. Buckle, R. H. Law, R. E. Butcher, W. T. Kan, C. H. Bird, K. 
Ung, K. A. Browne, K. Baran, T. A. Bashtannyk-Puhalovich, N. G. Faux, W. 
W ong, C. J. Porter, R. N. Pike, A. M. Ellisdon, M. C. Pearce, S. P. Bottomley,
J. Emsley, A. I. Smith, J. Rossjohn, E. L. Hartland, I. Voskoboinik, J. A. 
Trapani, P. I. Bird, M. A. Dunstone, and J. C. W hisstock. 2007. A common 
fold mediates vertebrate defense and bacterial attack. Science 317:1548-1551. 
Shirai, M., H. Hirakawa, M. Kimoto, M. Tabuchi, F. Kishi, K. Ouchi, T. Shiba, K. 
Ishii, M. Hattori, S. Kuhara, and T. Nakazawa. 2000. Comparison o f whole 
genome sequences o f Chlamydia pneumoniae  J138 from Japan and CWL029 
from USA. Nucleic Acids Res. 28:2311 -2314.
Smith, G. A., H. Marquis, S. Jones, N. C. Johnston, D. A. Portnoy, and H. Goldfine. 
1995. The two distinct phospholipases C o f  Listeria monocytogenes have 
overlapping roles in escape from a vacuole and cell-to-cell spread. Infect. Immun. 
63:4231-4237.
Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. M arathe, L. Aravind, W. 
M itchell, L. Olinger, R. L. Tatusov, Q. Zhao, E. V. Koonin, and R. W. Davis. 
1998. Genome sequence o f  an obligate intracellular pathogen o f  humans: 
Chlamydia trachomatis. Science 282:754-759.
Su, H., G. M cClarty, F. Dong, G. M. Hatch, Z. K. Pan, and G. Zhong. 2004. 
Activation o f  Raf/MEK/ERK/cPLA2 signaling pathway is essential for 
chlamydial acquisition o f host glycerophospholipids. J. Biol. Chem. 279:9409- 
9416.
Swanson, K. A., L. D. Taylor, S. D. Frank, G. L. Sturdevant, E. R. Fischer, J. H. 
Carlson, W. M. W hitmire, and H. D. Caldwell. 2009. Chlamydia trachomatis 
polymorphic membrane protein D is an oligomeric autotransporter with a higher- 
order structure. Infect. Immun. 77:508-516.
Tamura, A., A. M atsumoto, G. P. M anire, and N. Higashi. 1971. Electron 
microscopic observations on the structure o f  the envelopes o f  mature elementary 
bodies and developmental reticulate forms o f  Chlamydia psittaci. J. Bacteriol. 
105:355-360.
Thomson, N. R., M. T. Holden, C. Carder, N. Lennard, S. J. Lockey, P. Marsh, P. 
Skipp, C. D. O'Connor, I. Goodhead, H. Norbertzcak, B. Harris, D. Ormond, 
R. Ranee, M. A. Quail, J. Parkhill, R. S. Stephens, and I. N. Clarke. 2008.
58
Chlamydia trachomatis: genome sequence analysis o f  lymphogranuloma
venereum isolates. Genome Res. 18:161-171.
Thomson, N. R., C. Yeats, K. Bell, M. T. Holden, S. D. Bentley, M. Livingstone, A. 
M. Cerdeno-Tarraga, B. Harris, J. Doggett, D. Ormond, K. M ungall, K. 
Clarke, T. Feltwell, Z. Hance, M. Sanders, M. A. Quail, C. Price, B. G. 
Barrell, J. Parkhill, and D. Longbottom. 2005. The Chlamydophila abortus 
genome sequence reveals an array o f  variable proteins that contribute to 
interspecies variation. Genome Res. 15:629-640.
Whitworth, T., V. L. Popov, X. J. Yu, D. H. Walker, and D. H. Bouyer. 2005. 
Expression o f the Rickettsia prowazekii pld or tlyC gene in Salmonella enterica 
serovar Typhimurium mediates phagosomal escape. Infect. Immun. 73:6668- 
6673.
Wylie, J. L., G. M. Hatch, and G. M cClarty. 1997. Host cell phospholipids are 
trafficked to and then modified by Chlamydia trachomatis. J. Bacteriol. 
179:7233-7242.
Zehmer, J. K., Y. Huang, G. Peng, J. Pu, R. G. Anderson, and P. Liu. 2009. A role 
for lipid droplets in inter-membrane lipid traffic. Proteomics 9:914-921.
59
CH A PTER  TH R EE
CHLAM YDIA TRAC H O M ATIS  PO LY M O R PH IC  M EM B RA N E PRO TEIN  D IS AN 
O LIG O M ERIC A U TO TR A N SPO R TER  W ITH A H IG H ER -O R D ER ED  STRU CTU RE
3.1 A bstract
C hlam ydia trachom atis is a globally  im portant obligate intracellular bacterial 
pathogen that is a leading cause o f  sexually  transm itted disease and blinding trachom a. 
Effective control o f  these diseases will likely require a preventative vaccine. C. 
trachom atis  polym orphic m em brane protein D (Pm pD ) is an attractive vaccine candidate 
as it is conserved am ong C. trachom atis and is a target o f  b roadly  cross-reactive 
neutralizing antibodies. W e show  here that im m unoaffinity-purified native Pm pD exists 
as an oligom er w ith a distinct 23 nm flow er-like structure. Tw o-dim ensional blue 
native/SD S-PA G E analyses show ed oligom ers w ere com prised o f  lull length PmpD 
( p i55) and two proteolytically  processed fragm ents: p73 passenger dom ain (PD) and p82 
translocator dom ain. W e also show  that Pm pD undergoes an infection-dependent 
proteolytic processing step late in the grow th cycle that yields a soluble extended PD 
( p i l l )  that was processed into a p 7 3  PD and a novel p30 fragm ent. Interestingly, soluble 
Pm pD peptides possess putative eukaryotic-interacting functional m otifs im plicating 
potential secondary functions w ithin or distal to infected cells. C ollectively our findings 
show  Pm pD exists as two distinct forms: a surface-associated oligom er exhibiting  a 
higher ordered flow er-like structure and a soluble form  restricted to infected cells. W e 
hypothesize that Pm pD is a m ultifunctional virulence factor im portant in chlam ydial 
pathogenesis and could represent novel vaccine o r drug targets for the control o f  hum an 
chlam ydial infections.
3.2 Introduction
C hlam ydia trachom atis is a m ucosotropic obligate intracellular G ram -negative 
pathogen that is a leading cause o f  sexually transm itted and ocular infections. Infection 
can result in serious sequelae such as infertility  and blindness (W hitcher et a l ,  2001; 
W H O , 2001), and an increased risk for HIV  infection and transm ission (Plum m er, 1991). 
The pathophysiology o f  chlam ydial infection is associated w ith the pathogen’s propensity 
to cause persistent infection and to suppress host im m unity (B runham  and R ey-Ladino, 
2005). A vaccine is needed to control chlam ydial diseases; how ever, progress toward 
this goal will not be forthcom ing until m ore is know n about virulence factors m ediating
persistence and im m une evasion.
C hlam ydiae are characterized by a unique biphasic developm ental cycle that 
m odulates betw een an extracellu lar m etabolically  inactive infectious elem entary body 
(EB) and an intracellular m etabolically  active non-infectious reticulate body (RB) 
(M oulder, 1991). T heir obligate in tracellu lar n iche and the lack o f  a tractable genetic 
system  present unique challenges in the study o f  chlam ydial biology and pathogenesis. 
To overcom e these hurdles chlam ydial genom es from  a d iverse spectrum  o f  host-specific 
strains have been sequenced. C om parative genom ics have show n considerable hom ology 
am ong various chlam ydial species and have provided im portant insights into shared and 
species-specific virulence factors (C arlson e t al.. 2005: K alm an et al., 1999; R ead et al. 
2000; R ead et al., 2003; Stephens et a l ,  1998; T hom son e t al., 2008).
The type V or autotransporter (AT) secretion pathw ay is the m ost w idespread 
secretion m echanism  em ployed b y  G ram -negative bacteria to deliver virulence factors 
involved in initiating infection, d isease progression and im m une evasion [review ed in 
(D autin and Bernstein, 2007; H enderson e t al., 2004)]. A T  proteins are characterized by 
three dom ains: (i) a signal sequence (SS), (ii) a d iverse N -term inal passenger dom ain 
(PD) that confers effector function, and (iii) a conserved C -term inal translocator dom ain 
(TD). The TD  inserts into the outer m em brane (O M ) by  assem bling into a (3-barrel pore 
that facilitates PD translocation to the bacterial surface. The PD rem ains tethered to the 
TD  or is cleaved and either released or rem ains non-covalently  associated w ith the OM. 
W ell-characterized exam ples o f  ATs found on the bacterial cell surface as m onom ers or
61
oligomers are Neisseria meningitidis NalP (Oomen et al., 2004) and Helicobacter pylori 
VacA (Lupetti et al., 1996), respectively.
C. trachomatis has a nine-member AT family (Henderson et al., 2004), termed 
polymorphic membrane proteins (Pmps), whose role(s) in chlamydial pathogenesis has 
yet to be defined. The pm p  paralogs {pmpA-I) constitute 3.2% o f  the ~1 Mb genome and 
are found at three chromosomal loci comprised o f  two gene clusters (pmpA-C  and pmpE- 
I) and the genetically isolated pmpD  (Stephens et al., 1998). Notably, PmpD is the 
second most highly conserved Pmp, exhibiting 99.2% amino acid identity among C. 
trachomatis serovars (Gomes et al., 2006). Despite relatively low abundance in the 
chlamydial OM, Pmps are major immunogens and may be important virulence factors 
(Longbottom et al., 1998). C. trachomatis PmpD is a target o f  broadly cross-reactive 
neutralizing antibodies (Abs) making it an attractive vaccine candidate for the prevention 
o f  human infections (Crane et al., 2006)
Previous reports have described proteolytic processing o f  C. pneumoniae  and C. 
trachomatis PmpD (Kiselev et al., 2007; Wehrl et al., 2004). Furthermore, recombinant 
C. pneumoniae  PmpD has been suggested to function as an adhesin capable o f inducing 
pro-inflammatory cytokine production (Niessner et al., 2003; Wehrl et al. 2004). 
Nothing is known about the native structure o f  C. trachomatis PmpD or the potential 
significance o f  its structure to chlamydial pathogenesis. Here we show that C. 
trachomatis PmpD is present on the organism ’s surface as an oligomer with a higher- 
ordered flower-like structure. Moreover, we describe novel infection-dependent 
proteolytic processing o f  PmpD that produces soluble fragments with predicted 
eukaryotic motifs implicating a multifunctional protein important to chlamydial 
pathogenesis.
3.3 Materials and Methods
3.3.1 Chlamvdiae, antibodies, and W estern blotting.
C. trachomatis serovars L2/LGV-434 and D/UW-3 EBs and RBs were propagated 
and purified as previously described (Caldwell et al., 1981), except the band at the 40- 
44% interface was harvested for RB. For PmpD purification and solubility experiments,
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L2 was grown in L929 cell suspension cultures and harvested by  30%  density  gradient 
centrifugation as described (Caldw ell et al., 1975). Rabbit polyclonal Abs w ere 
generated against C. trachom atis serovar A /H AR-13 Pm pD peptides (Q uality  C ontrolled 
B iochem icals; Fig. 16A and Fig. 20C): Pm pD -N , R LIV G D PSSFQ EK D A D T L (aa 76- 
93); Pm pD -M , A LFA SED G D LSPESS (aa 761-775); Pm pD -C ', 
Q Q G H A ISK PEA EIESSSE (aa 1041-1058) and Pm pD -C, K N EA K V PLM SFV A SG D EA  
(aa 1136-1153). O ther A bs used w ere m ouse anti-m ajor outer m em brane protein 
(M OM P; L2I-45), rabbit anti-L2 EB, and m ouse anti-chlam ydial protease-like activity 
factor (CPAF) (D ong et a l., 2004). Purified EBs or RBs w ere solubilized in Laem m li 
buffer, electrophoresed on 4-15%  Criterion gels (B ioR ad), transferred to a polyvinylidene 
diflouride (PV DF) m em brane and W estern blotted.
3.3.2 Im m unoaffinitv purification o f  PmpD.
The Pm pD -M  Ab w as coupled to A ffiG el 10 (B io-R ad) according to the 
m anufacturer’s protocol. T he colum n w as pretreated  w ith  elution buffers 50 mM  
glycine-H Cl, pH  2.3 and 3 M  Nal. For Pm pD  purifications, EB pellets w ere resuspended 
at 1010 IFU/m l in ice-cold 1% octyl (3-D-glucopyranoside (O G P) in phosphate buffered 
saline (PBS), pH 7.4 containing C om plete protease inhibitor cocktail (R oche), incubated 
for 30 m in  at 37°C, and ultracentrifuged at 100,000 x g  for 1 h  at 4°C. T he Pm pD- 
containing extract w as passed over the colum n tw ice, washed w ith 0.1%  O G P, PBS, pH 
8.0 containing increasing concentrations o f  N aCl. Pm pD w as acid-eluted w ith 0.1%  
OGP, 50 mM  glycine-H Cl, pH 2.3 containing protease inhibitors and directly  neutralized 
w ith 1 M Tris, 0.15 M N aCl, pH 8.0; or eluted w ith 0.1%  OGP, 3 M  N al containing 
protease inhibitors and dialyzed into 0.01%  OGP, PBS, pH  7.4.
3.3.3 Sequence analysis.
Im m unoaffm ity purified Pm pD  (-4 0  pg) w as pooled, precipitated w ith 
trichloroacetic acid, separated by  SD S-PA G E, stained w ith G elC ode Blue, excised and 
subm itted for sequence analysis (H arvard M icrochem istry and Proteom ics A nalysis 
Facility, Boston, M A). Sam ples w ere digested w ith  chym otrypsin, G luC, and elastase 
follow ed by  m icrocapillary reverse-phase HPLC nano-electrospray tandem  m ass
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spectrometry (pLC/M S/M S) on a Thermo LTQ-Orbitrap mass spectrometer. Edman 
degradation for N-terminal sequencing was performed by the Research Technologies 
Branch NIAID/NIH, Bethesda, MD.
3.3.4 PmpD solubility.
L2 infected L929 suspension cultures were harvested by centrifugation, washed in 
PBS and sensitized with hypo-osmotic swelling medium (15 mM KC1, 1.5 mM 
magnesium acetate tetrahydrate and 10 mM HEPES-KOH, pH 7.4) containing Complete 
protease inhibitor cocktail (Roche). Cells were gently lysed by 20 strokes o f a 0.05 mm 
clearance pestle in a dounce homogenizer. Insoluble and soluble fractions were prepared 
as previously described (Fan et al., 1998).
3.3.5 Confocal microscopy.
L2 infected HeLa 229 cells were methanol fixed 28 h post infection and 
sequentially labeled with rabbit anti-PmpD, AlexaFluor 488-conjugated goat anti-rabbit 
IgG (Invitrogen), mouse anti-MOMP, and AlexaFluor 568-conjugated goat anti-mouse 
IgG (Invitrogen). Monolayers were extensively washed between each step, and DNA 
was stained with DRAQ5 (Alexis). Images were acquired using a Carl Zeiss LSM 510 
confocal laser scanning microscope (Carl Zeiss Micro Imaging) equipped with a 63x, 1.4 
NA oil immersion objective and processed using Adobe Photoshop CS2 (Adobe Systems 
Inc.).
3.3.6 Two-dimensional blue native/SDS-PAGE and electroelution.
Two-dimensional blue native/SDS-PAGE (2D BN/SDS-PAGE) was performed as 
described (W ittig et al., 2006) with the following modifications. BN-PAGE samples 
were electrophoresed on 4-15% Criterion XT Bis-Tris gels (Bio-Rad) at 100 V for 30 
min. then increased to 500 V with a 40 mA threshold, using anode buffer (25 mM 
imidazole, pH 7.0) and cathode buffer (50 mM tricine, 7.5 mM imidazole, 0.02% 
Coomassie blue G-250, pH 7.0). Electrotransfer to PVDF was performed in 50 mM 
tricine, 7.5 mM imidazole, pH 7.0 with 75 V/200 mA maximum thresholds for 3 h at 
4°C. For 2D BN/SDS-PAGE, a single lane was excised from BN-PAGE gel, boiled in
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1% SDS and 1% 2-ME and loaded into a 4-15% Criterion gel (Bio-Rad) prep well 
underlayed with 0.5% agarose. Second dimension SDS-PAGE and immunoblotting was 
performed as described above. To electroelute oligomers, BN-PAGE and Western blot 
was performed. An -850  kDa immunoreactive band was excised from an overlayed 
unstained duplicate gel and proteins were eluted with a model 422 electro-eluter (Bio- 
Rad) for 14 h at 2 mA/elution chamber using 0.01% OGP, 25 mM tricine, 3.75 mM 
imidazole and 5 mM 6-aminohexanoic acid buffer.
3.3.7 Electron microscopy.
Electroeluted PmpD oligomers were adsorbed to carbon-coated formvar 200 mesh 
copper grids and negatively stained with 2% (w/v) aqueous ammonium molybdate. 
Purified L2 EBs were adsorbed on copper grids, immunolabeled in a Pelco3451 
laboratory microwave oven (Ted Pella Inc.) (Rangell and Keller, 2000) using PmpD-M 
Ab and 5 nm colloidal gold (BBIntemational) as secondary Ab, and negatively stained. 
Purified D EBs and RBs were pelleted, fixed in 4% paraformaldehyde and 2.5% 
glutaraldehyde in 0.1 M sodium cacodylate buffer pH 7.2 and sectioned. Images were 
acquired on a Philips C M -10 transmission electron microscope (TEM; FEI) at 60 kV or 
80 kV. Focused and defocused images were acquired and analyzed using a bottom 
mount AMT digital camera system (ATM). Over 100 purified oligomers were measured 
for two independent experiments to determine the diameter. Statistical analysis was 
performed using a two-tailed student’s t test. Scanning electron microscopy (SEM) was 
performed as previously described (Crane et al., 2006). All images were processed with 
Adobe PhotoShop CS2 (Adobe Systems Inc.).
3.4 Results
3.4.1 Structural features and proteolytic processing o f  PmpD.
The structural features o f  C. trachomatis PmpD are shown in Fig. 16A. PmpD 
shares many characteristics found in ATs including a relatively large size (1530 aa, 160.5 
kDa), N-terminal GGA[I/L/V] and FXXN tetrapeptide repeats (Grimwood and Stephens, 
1999), an integrin-binding RGD m otif (aa 698-670) (Takada et al., 2007), and a putative
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nuclear localization signal (NLS; aa 783-798). The N LS is a bipartite m o tif  defined by 
two clusters o f  basic residues separated by  a stretch o f  nine am ino acids (K R R X 9KRV R) 
(Boulikas, 1993).
W e generated Abs specific to peptides located in the N -term inal (Pm pD -N ), 
m iddle (Pm pD -M ), and C-term inal (Pm pD -C ) regions o f  Pm pD  (Fig. 16A) to study 
proteolytic processing o f  the protein. C oom assie stained gels o f  EB lysates exhibited a 
relatively low  abundance o f  Pm pD com pared to the 40 kD a M O M P. W estern blots w ith 
Pm pD Abs show ed specific im m unoreactivity  w ith the m ature protein ( p i 55) and two 
predom inant low er m olecular w eight proteins, p82 and p73 (F ig 16B). B ased on these 
results we concluded that p73 was the N -term inal PD and p82 w as the C-term inal TD. 
The N-term inal h a lf  o f  Pm pD  is cysteine-rich suggesting potential for disulfide bond 
interactions. W e found no evidence for interm olecular Pm pD disulfide bonding as no 
supram olecular com plexes w ere observed in sam ples solubilized w ithout 2-M E. 
H ow ever, a subtle but reproducible increase in the electrophoretic m obility  o f  the p73 PD
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Figure 16. Structural features and proteolytic processing o f PmpD. (A) C. trachom atis  
PmpD (aa 1-1530) contains GGA[I/L/V ] and FXXN tetrapeptide repeats and cysteine 
residues (C) concentrated in the N-term inal half o f the protein. An RGD sequence (red) is 
located w ithin a predicted (3-helix adjacent to a putative nuclear localization signal (NLS; 
yellow). Rabbit anti-Pm pD polyclonal Abs were generated against am ino acids indicated by 
the dashed lines. (B) C. trachom atis  serovar L2 EBs were prepared fo r SDS-PAGE and 
Coom assie-stained (CBB) or immunoblotted w ith anti-Pm pD Abs. The m ature protein 
(p155) and two m ajor processed form s, an N-term inal p73 and C-term inal p82, were 
detected. ____________________________ _______
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was observed im plicating in tram olecular disulfide bonding w ithin this fragm ent (data not 
shown).
3.4.2 Im m unoaffinitv purification o f  native Pm pD ,
W e screened a panel o f  non-ionic detergents for the ability  to extract Pm pD  from 
EBs to purify the native protein by im m unoaffinity  chrom atography. C oom assie stained 
gels indicated that a sm all fraction o f  the total chlam ydial proteins w ere solubilized in 
non-ionic detergents (Fig. 17A). W estern b lots using Pm pD -M  A b show  that C. 
trachom atis Pm pD  is unique as it was efficiently  extracted from  EBs in a soluble form  by 
non-ionic detergents (Fig. 17B). This is in contrast to other Pm ps that are retained in the 
Sarkosyl insoluble OM  fraction (Tanzer et al., 2001). W e used OGP to extract PmpD 
from  EBs and purified the protein b y  im m unoaffinity  chrom atography (Fig. 18A). A 
single 155 kD a polypeptide (Fig. 18A, arrow head) w as observed in the eluted fractions 
follow ing C oom assie staining. W estern blot analysis w ith the Pm pD -M  Ab detected 
m ature p i 55 and the p82 TD. Elution fractions w ere pooled, concentrated, and analyzed 
by  W estern b lo t and silver stain (Fig. 18B). C onsistent w ith Pm pD  from  w hole EB 
lysates, im m unoaffinity  purified Pm pD w as com prised predom inantly  o f  the m ature 
p i 55, N-term inal p73 and C-term inal p82. W e concluded that p73 and p82 w ere the
A  PBS TX-100 NP-40 OGP B  PBS TX-100 NP-40 OGP
E B P S P S P S  P S  E B P S P S P S  P S
2 5 0 -
5 0 -
3 7 -
2 5 -
CBB a-PmpD-M
Figure 17. PmpD is extracted from chlam ydiae by non-ionic detergents. C. trachomatis 
serovar L2 EBs were incubated in 1% solutions of Triton X-100 (TX-100), Igepal CA630 (NP- 
40), Octyl ® -D -glucopyranoside (OGP), or PBS fo r 30 min and centrifuged at 100,000 x g fo r  1 
h. 1 x 108 detergent-treated EBs (P) and an equivalent volum e of detergent extracts (S) were 
separated by SDS-PAGE and either (A) Coom assie stained or (B) im m unoblotted w ith the 
PmpD-M Ab. PmpD was effic iently extracted w ith non-ionic detergents, especially OGP, as 
the m ajority o f protein was found in the supernatant (S) and not the pellet (P).________________
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naturally processed PD and TD, respectively; a finding in agreement with previously 
published reports (Kiselev et a l 2007; Wehrl et al. 2004).
W e performed N-terminal sequence analysis o f p i 55 and p82 fragments (Fig. 
18C). Edman degradation o f p i 55 identified 53VLLLDQ as the mature N-terminus. 
Sequence analysis o f  p82 identified the N-terminus as “LFASEDGDLS. These results 
are the first to describe the precise location o f  PmpD proteolytic cleavage sites that define 
the mature PD and TD. They also indirectly define the PmpD signal sequence as an 
extended 52 amino acid sequence; similarly large signal sequences have been described 
for other type V AT (Dautin and Bernstein, 2007).
Elution 
FT fractions
Elution 
FT fractions
B
S 1 2 V 1  2 3 4 5 6  S 1  2 V  1 2 3 4 5 6
170. _  ___________________
130'
95- 
72-
3 4 - ____
26-
Purified PmpD
17
CBB a-Pm pD-M
250-
ISO--
100-
75-0
50--
37-
25-
-p155
-p82
-p 73
N M
PmpD Ab
Silver
stain
p82 Translocator domainp73 Passenger domain
53VLLLDQ 762l f a s e d g d l s
Figure 18. Im m unoaffin ity purification of native PmpD. (A) PmpD was extracted from  L2 
EBs using 1% OGP and purified by im m unoaffinity chrom atography using the PmpD-M Ab. 
Column fractions were separated by SDS-PAGE and C oom assie-stained or processed for 
im munoblotting w ith the PmpD-M Ab. S, OGP supernatant; FT, flow  through; V, colum n void 
volum e. (B) Pooled and concentrated eluates were exam ined by W estern blot and silver 
stain. The m ajor products were p155, p82, and p73. PmpD-M was w eakly reactive w ith an 
-1 0 0  kDa polypeptide and all Abs recognized a 50 kDa polypeptide that w ere identified by 
mass spectrom etry as PmpD and rabbit IgG heavy chain, respectively. (C) Identification of 
PmpD proteolytic processing sites (black arrows). C leavage of the signal sequence (gray) 
between A52 and V53 was identified by im m unoprecipitation o f PmpD from OG P-extracted L2 
EBs and N-term inal sequencing. To identify the cleavage site that produced the N-terminal 
p73 PD (white) and C-term inal p82 TD  (black) im m unoaffinity purified PmpD was TCA 
precipitated, separated by SDS-PAGE, stained w ith Coom assie and excised. Mass 
spectrom etry analysis was performed as described in experim ental procedures. The cleavage 
site was identified between A761 and L762.
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3.4.3 Pm pD exhibits unique staining properties.
Pm pD w as exam ined by confocal m icroscopy o f  C. trachom atis  infected HeLa 
cells im m unolabeled w ith Pm pD - and M O M P-specific Abs (Fig. 19). Pm pD -M  Ab 
exhibited strong OM  staining sim ilar to M O M P but also presented as diffuse intra­
inclusion staining and as bright punctate clusters (Fig. 19A). R esolution lim its o f  light 
m icroscopy precluded us from differentiating w hether these punctate structures w ere on 
the organism s’ surface or free w ithin the inclusion. Pm pD -C Ab intensely stained the 
OM  but reacted w eakly  w ith the punctate structures (Fig. 19B). Pm pD -C Ab did not 
exhibit the diffuse intra-inclusion staining found w ith both Pm pD -M  and Pm pD -N  Abs 
(Fig. 19 and data not shown). W e did not detect Pm pD  beyond the inclusion lum en in 
infected cells, consistent w ith previous studies (K iselev et a l ., 2007; W ehrl e t al. 2004). 
These findings suggest that Pm pD exists as m ultiple structures in infected cells including 
organism  associated and soluble form s generated by possible secondary cleavage events.
A pll
a-Pm pD -M  ct-MOMP overlay
B■[■' ]
ct-Pm pD -C ct-MOMP overlay
Figure 19. PmpD exhibits unique staining properties. C. trachom atis  infected HeLa 
cells were methanol fixed at 28 h post infection and immunolabeled w ith (A) PmpD-M or (B) 
PmpD-C and M O M P-specific Abs. PmpD (green) localized to chlam ydial OM s (filled 
arrows) and to punctate clusters w ith in the inclusion lumen (arrowheads). D iffuse intra­
inclusion staining detected with PmpD-M Ab (open arrows) was not seen w ith Pm pD-C Ab. 
A single confocal plane is shown. MOMP is labeled red, and DNA (blue) is shown in the 
I overlay. Scale bar. 5 mm.  __
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3.4.4 PmpD is proteolvticallv processed to soluble forms late in infection.
To more thoroughly examine PmpD expression C. trachomatis infected cells were 
harvested at various hours post infection, dounce homogenized and subjected to 
ultracentrifugation to obtain soluble and insoluble fractions. We analyzed the fractions 
by Western blot with our panel o f PmpD Abs (Fig. 20). Anti-MOMP and CPAF Abs 
were used as positive controls for insoluble and soluble chlamydial proteins, respectively. 
As expected both proteins were first detected at mid-growth cycle with MOMP being 
present only in the insoluble fraction and CPAF in both the insoluble and soluble 
fractions. Full length p i 55, p82 TD, and p73 PD were detected in the insoluble fractions 
beginning at 24 h post infection (Fig 20A). Consistent with our microscopy data, the 
PmpD-C Ab was immunoreactive with the insoluble fractions suggesting the C-terminus 
o f  PmpD remains organism associated (Fig. 20A). Interestingly, the PmpD-N Ab 
detected a 111 kDa fragment ( p i l l )  and p73 in the soluble fractions late in the 
developmental cycle (Fig. 20B). PmpD-M Ab recognized the same p i l l ,  but also 
reacted with a novel 30 kDa polypeptide (p30). The p i l l  and p73 soluble forms are 
likely the previously reported 120 kDa and 67 kDa polypeptides (Kiselev et a i,  2007). 
However, to our knowledge this is the first description o f the soluble p30. W estern blot 
analysis with the PmpD-C' Ab, which lies upstream o f  PmpD-C, showed reactivity 
against both p i l l  and p30 (Fig. 20B). This indicates that pi 11 is generated by cleavage 
between aa 1058-1136 and that the p30 originates from the C-terminal end o f  p i 11 (Fig. 
20C). Collectively, these findings demonstrate that PmpD undergoes multiple proteolytic 
cleavage events: (i) primary processing to produce organism-associated p73 PD and p82 
TD and (ii) late infection-dependent secondary processing to generate a soluble extended 
PD ( p i l l )  that is further cleaved to produce solublep73 PD and p30 (Fig. 20C).
3.4.5 Native PmpD is an oligomer with a flower-like structure.
Immunoaffinity-purified PmpD from EBs (Fig. 18B) was analyzed by BN-PAGE 
and TEM. BN-PAGE relies on Coomassie blue G250 to impose a negative charge shift 
on detergent-extracted membrane proteins under neutral pH and non-denaturing 
conditions (W ittig et a i,  2006). BN-PAGE W estern blots o f PmpD revealed a complex 
pattern o f high molecular weight oligomers ranging from -250-1050 kDa with stronger
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processed to soluble form s late 
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reactivity observed at -5 3 0  kDa and -8 5 0  kDa (Fig. 21A and B). Complexes o f  -5 3 0  
kDa and -8 5 0  kDa correspond to oligomers composed o f 4-5 and 5-6 subunits, 
respectively. The PD was also detected as a single -1 0 0  kDa band (Fig. 21 A, top panel). 
The composition o f the oligomers was defined by 2D BN/SDS-PAGE and Western 
blotting with either PmpD-N (Fig. 21 A) or PmpD-C (Fig. 2 IB) Abs. These results
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show ed that oligom ers were com posed o f  full length p i 55, p73 PD and p82 TD. Purified 
PmpD oligom ers did not contain detectable p i  11 or p30 fragm ents (Fig. 21A and data not 
show n) that w ere found in the soluble fractions o f  infected cells (F ig 20B).
Pm pD oligom ers (-8 5 0  kDa) w ere excised, electroeluted, negatively stained, and 
exam ined by TEM  (Fig. 21C and D). Im aging show ed the oligom ers w ere a hom ogenous 
population o f  particulate structures that exhibited a 23 ± 3 nm  (p<0.0001) ring 
surrounded by 5-6 sym m etrically arrayed petals to form  a flow er-like structure (Fig. 
2 ID). These characteristics are rem arkably sim ilar to the rosettes described by 
M atsum oto follow ing freeze-deep-etching o f  chlam ydial organism s (M atsum oto, 1982b) 
and the secreted PD o f / / ,  p ylo ri V acA  (C over et al., 1997).
Figure 21. Native PmpD is a flow er-like oligom er com posed of full length and 
processed form s. W estern blots o f 2D BN/SDS-PAG E gels of im m unoaffinity purified PmpD 
were performed using either (A) PmpD-N or (B) PmpD-C Abs. First dim ension BN-PAGE 
showed PmpD migrated from 250-1050 kDa and as a discrete band at 100 kDa. PmpD 
oligom ers were dissociated by second dim ension SDS-PAGE into p155, p82 and p73. (C) 
TEM was performed on negatively stained electroeluted -8 5 0  kDa PmpD oligom ers. Scale 
bar, 100 nm. (D) A magnified oligom er (arrowhead in C) displayed a distinct flower-like 
structure w ith a central core and sym m etrically-arrayed petals. Scale bar, 25 nm._____________ |
3.4.6 Localization o f  Pm pD oligom ers on the chlam ydial surface.
A Ts that perform  critical pathogenic functions are know n to localize to one pole 
or distinct locations in the bacterial OM  (Jain et al., 2006; Shapiro et al., 2002).
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Figure 22. Polarized PmpD distribution on the EB 
surface. (A-C) L2 EBs were fixed in 4% 
paraformaldehyde, labeled w ith either anti-L2 EB, 
anti-M OMP, or anti-PmpD-M and secondary Ab 
conjugated to 5 nm gold, and imaged by TEM. (D-F) 
L2 EBs w ere adsorbed to silicon chips and labeled as 
described for A-C  except 10 nm gold was used and 
EBs w ere fixed post-labeling and imaged by SEM. In 
contrast to hom ogeneous MOMP distribution, PmpD 
was sparse and appeared in polarized clusters 
(arrowheads) on the OM. One cluster is shown at a 
higher magnification (F, inset). The concentric 
distribution of gold particles suggests oligom eric 
forms. Scale bars: A-F, 50 nm; F inset, 25 nm.
Interestingly, EM o f  anti-PmpD 
immunogold-labeled EBs showed 
asymmetric localization o f  PmpD 
oligomers (Fig. 22C and F). This 
was in contrast to the abundant and 
uniform staining observed 
following anti-EB or MOMP 
labeling (Fig. 22A, B, D and E). 
The polarization o f PmpD 
oligomers was observed on the 
majority o f EBs examined and is 
consistent with the bright punctate 
structures observed by confocal 
microscopy (Fig. 19A). This 
clustering is suggestive o f  the 
asymmetric hemispheric
projections described on the 
surface o f both C. psittaci and C. 
trachomatis EBs (Gregory et al., 
1979; Matsumoto, 1982a). PmpD 
distribution on EBs was compared 
to purified RBs. C. trachomatis 
RBs and EBs were purified to 
relative homogeneity by density 
gradient centrifugation (Fig. 23A). 
Western blots and SEM showed
PmpD oligomers were more abundant on purified RB than EB (Fig. 23B and C). Also, a 
more homogeneous distribution o f  PmpD was observed on RBs in contrast to a more 
polarized localization on EBs (Fig. 23B).
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3.5 Discussion
In contrast to other G ram -negative organism s, C. trachom atis  has a 
disproportionately large num ber o f  AT genes relative to its genom e size suggesting the 
chlam ydial type V secretion proteins p lay  an im portant role in pathogenesis. W e report 
here that C. trachom atis Pm pD is an oligom eric AT that undergoes m ultip le proteolytic 
processing steps to produce organism  associated and soluble forms. Prim ary proteolytic 
processing o f  Pm pD results in m em brane associated oligom ers com posed o f  m ature 
p i 55, p73 PD and p82 TD. B iochem ical characterization o f  im m unoaffinity-purified
Figure 23. Differential distribution and abundance of PmpD on C. trachom atis  EBs 
and RBs. (A) Purified C. trachom atis serovar D RBs and EBs were pelleted, sectioned and 
imaged by TEM  to demonstrate hom ogeneity and purity of the chlam ydial preparations. 
Scale bar, 500 nm. (B) SEM of a serovar D RB and EB immunolabeled w ith anti-PmpD-M 
Abs and 10 nm colloidal gold. Scale bar, 50 nm. The anti-Pm pD staining is more evenly 
distributed fo r RB than EB. (C) CBB and western blots of equivalent am ounts o f purified D 
RB and EB protein (15 pg) were probed w ith the PmpD-M Ab. C onsistent w ith a higher 
density of PmpD on the RB surface shown in B, imm unoblots dem onstrate more PmpD in 
RBs com pared to EBs.
C
RB EB
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1
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PmpD oligom ers dem onstrated they w ere ~23 nm  flow er-like m olecules asym m etrically 
positioned on the EB surface. T hese structures are rem arkably sim ilar to the surface 
projections that localize in hexagonal clusters on C. psittaci EBs (M atsum oto, 1982b). 
The surface projections or rosettes described by M atsum oto and others (Chang et al., 
1982; G regory e t a l ,  1979; So loff et al., 1982) are speculated to be part o f  the chlam ydial 
type III secretion apparatus (Bavoil and Hsia, 1998). H ow ever, w e show here that the 
Pm pD oligom er size, flow er-like structure, abundance on RBs, and asym m etric 
localization on EBs are all features shared b y  M atsum oto’s surface projections. Thus, 
our data suggest the previously described surface projections could be  Pm pD oligom ers, 
but does not exclude the possibility  that other proteins could form  sim ilar structures. As 
the other eight p m p  fam ily m em bers are all expressed during infection (G rim w ood et al., 
2001; Nunes et al., 2007), any o f  the Pm ps could serve as candidates. The question 
rem ains w hether these Pm ps exist as m onom ers o r oligom ers and i f  they interact w ith 
Pm pD  in the OM.
Im portantly, w e present new findings show ing a late infection-dependent 
secondary Pm pD  processing step resulting in soluble p i l l ,  p73, and p30 fragm ents, 
p i l l  and p30 w ere not detected in im m unoaffinity-purified oligom ers bu t w ere observed 
in the inclusion lum en by confocal m icroscopy. H ow ever, we cannot exclude the 
possibility  they are secreted into the host cytosol as show n for o ther chlam ydial proteins 
(D ong et al., 2006; K leba and Stephens, 2008; Li et al., 2008; Z hong et al., 2001). 
Bacterial effectors secreted into the host cells at low levels are undetectable by 
im m unofluorescence (K ujat C hoy et al., 2004), suggesting lim ited quantities o f  PmpD 
m ay exist in the host cytosol. Soluble form s o f  Pm pD are not likely structural but are 
possible effectors that function either in the host cell during late stages o f  infection or on 
neighboring cells after release o f  the inclusion into the extracellular environm ent 
(H ybiske and Stephens, 2007; Todd and Caldw ell, 1985).
C leavage o f  the soluble p i l l  results in a p73 PD and a novel C -term inal p30 
fragm ent. It is not know n i f  p i l l  processing is dependent on chlam ydial or host 
proteases o r i f  the soluble p73 and p30 rem ain stably associated after p i l l  cleavage. It is 
notew orthy how ever that p i l l  proteolysis separates the eukaryotic RGD and NLS m otifs 
to the p73 and p30 fragm ents, respectively, im plicating distinct effector functions for
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both polypeptides. H. pylori V acA and the N eisseria  IgA protease are exam ples o f  
m ultifunctional ATs that undergo proteolytic processing to generate distinct functional 
subunits. V acA  is secreted as a m ature 88 kD a toxin  that is cleaved into p33 and p55 that 
form  flow er-like oligom ers that function in toxin internalization and cytotoxicity  (Torres 
et al., 2005). The secreted PD o f  the N eisseria  IgA protease is processed to an NLS- 
containing a-p ro te in  that localizes to the host cell nucleus (Pohlner et al., 1995). Sim ilar 
to the a-pro tein , the N LS o f  Pm pD  p30 could target th is fragm ent to the nucleus. The 
p73 PD integrin-binding RGD m o tif is sim ilar to the PD s o f  B ordetella pertussis  
pertactin and E. coli Ag43 that function as adhesins (W ells et al., 2007). These structural 
sim ilarities suggest that soluble form s o f  Pm pD interact w ith receptors on epithelial cells 
or lym phocytes to produce pleiotropic effects im portant in pathogenicity. There are 
fascinating parallels betw een the structure o f  H. p y lo ri VacA and C. trachom atis PmpD 
and their host-pathogen relationships. Both are prim arily  hum an m ucosotropic pathogens 
that cause chronic inflam m atory disease and actively suppress host im m unity. H. pylori 
V acA oligom ers have T cell suppressive activity  (G ebert et al., 2003). Interestingly, 
chlam ydiae suppress the developm ent o f  m em ory CD8 T cells through an unknow n 
m echanism  (Loom is and S tam bach, 2006). It is tem pting to speculate that Pm pD m ay 
play a sim ilar role in T cell suppression.
A w orking m odel o f  C. trachom atis Pm pD structure and function is shown in 
Figure 24. The m odel is based on the experim ental findings presented here together w ith 
know n properties o f  bacterial ATs. W e propose tw o unique Pm pD  functions in the 
interaction o f  chlam ydiae w ith its host. First, w e suggest that EB surface associated 
oligom ers function in early host cell interactions to prom ote either chlam ydial attachm ent 
or entry. The m ost logical m echanism  for this function w ould be through the p73 PD 
RGD m o tif binding to its cognate host integrin receptor(s). Polarized Pm pD  oligom ers 
on the EB surface (Fig. 22) w ould be m ulti valent and could enhance this interaction. The 
ability o f  anti-Pm pD  Abs to inhibit chlam ydial infection (C rane et al., 2006; W ehrl et al., 
2004) indirectly supports this function. Secondly, soluble p i l l  produced late in the 
infection cycle possesses RGD and N LS m otifs that associate w ith the p73 PD and p30 
fragm ent, respectively. W e believe these secreted effectors have dow nstream  targets 
im portant to chlam ydial pathogenicity. For exam ple, through unknow n m echanism s
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Figure 24. A  model of C. trachom atis  PmpD
structure and function. W e propose two distinct 
PmpD functions in the interaction of chlam ydiae with 
host cells. The first involves the EB surface oligomers. 
W e suggest that these higher-ordered structures are 
important in chlamydial entry, a hypothesis supported 
by the ability o f anti-Pm pD Abs to block infection (10, 
52). The second function involves the soluble form s of 
processed PmpD present only late in the 
developm ental cycle. Processing of the p111 (dashed 
lines) segregates the RGD (red) and the putative NLS 
(yellow) motifs to p73 and p30, respectively, that may 
rem ain stably associated or exist separately. The 
soluble peptides could be limited to the inclusion lumen 
or access the host cell cytosol (dashed arrow). The 
NLS in the p30 fragm ent suggests it translocates to the 
nucleus to effect host transcription. The biological 
activity o f inclusion-restricted PmpD could depend on 
release into the extracellu lar environm ent after cell 
lysis or inclusion egression. W e believe that the p111 
PD is sim ilar to the H. py lo ri VacA PD (51), which 
dissociates after binding host receptors to deliver the 
NLS to uninfected or bystander cells and thus 
regulates host gene expression. This interaction could 
result in the induction o f apoptosis in uninfected 
epithelial cells and T cell suppression.
chlamydiae actively inhibit 
apoptosis early and promote 
programmed cell death late 
during infection to escape from 
the host cell (Byrne and Ojcius, 
2004). PmpD secreted into the 
host cytosol late in infection 
could be targeted to the nucleus 
by the eukaryotic NLS in the p30 
to regulate host gene expression. 
Following release from the 
inclusion into the extracellular 
environment (Hybiske and 
Stephens, 2007; Todd and 
Caldwell, 1985) they could act 
on additional cellular targets. C. 
trachomatis infected cells (>40 h 
post infection) have been shown 
to induce apoptosis of 
neighboring uninfected cells 
(Schoier et al., 2001). Moreover, 
chlamydial infections have 
potent T cell suppressive activity 
(Loomis and Stambach, 2006). 
The molecular mechanism(s) for 
these pathogenic activities are 
unknown but could be mediated 
by soluble PmpD peptide
fragments.
A more complete understanding o f PmpD oligomeric structure and its soluble 
peptide fragments is important as this information will be fundamentally critical in the
design o f  a PmpD-based vaccine. The results o f this study represent an important 
advancement towards this end. For example, native PmpD oligomers could represent key 
structures that elicit conformation-dependent broadly neutralizing Abs. Moreover, 
definition o f the natural proteolytic cleavage sites o f soluble PmpD fragments will be 
useful in the construction and expression o f biologically relevant recombinant proteins. 
A highly efficacious PmpD vaccine might require the incorporation o f  multiple protein 
targets capable o f inducing Abs that neutralize a broad spectrum o f PmpD-mediated 
biological activities.
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CHAPTER FOUR 
SUMMARY
4.1 Conclusions
Chlamydia trachomatis is the etiologic agent o f  the world’s leading cause o f 
preventable blindness and is the most commonly reported bacterial sexually transmitted 
infection in humans. Given the global impact on human health, there is a need to develop 
effective treatments and an efficacious vaccine. A better understanding o f  the chlamydial 
virulence factors that mediate persistent infection and evasion o f host immunity will be 
essential to the development o f  an effective vaccine against human chlamydial diseases. 
Chlamydiae are characterized by a complex developmental cycle that is unique among 
prokaryotes (Moulder, 1991), and the obligate intracellular lifestyle presents formidable 
challenges in the study o f chlamydial biology and pathogenesis. Genome sequencing of 
several chlamydial species and comparative genomic studies have helped to overcome 
these obstacles and have provided important insights into shared and species-specific 
virulence factors that underlie the pathogenic diversity in chlamydiae (Azuma et al., 
2006; Carlson et al., 2005; Kalman et a l ,  1999; Kari et al., 2008; Read et a l ,  2000; Read 
et al., 2003; Shirai et al., 2000; Stephens et a l ,  1998; Thomson et al., 2008; Thomson et 
al., 2005). Genes encoded in a hyper-variable region o f  the genome termed the plasticity 
zone (PZ) and the polymorphic membrane proteins (Pmps) emerged from these studies as 
potentially major virulence determinants for chlamydiae (Kalman et al., 1999; Read et 
al., 2000; Stephens et a l ,  1998). The goals o f my dissertation research have been to 
understand the role o f  a member from each o f these families in chlamydial pathogenesis. 
Chapter two provides the first biological characterization o f  the PZ MAC/perforin 
(MACPF) domain containing protein CT153 and suggests this protein functions within a 
specific subset o f reticulate bodies (RBs) that acquire lipids from host cells. Chapter 
three describes the native structure o f PmpD and shows that proteolytic processing o f  the 
protein produces soluble fragments with predicted eukaryotic interacting motifs 
implicating a multifunctional virulence factor important to chlamydial pathogenesis.
4.1.1 The plasticity zone MACPF domain family protein CT153.
The sequenced C. trachomatis strains are more than 99.5% identical at the nucleic 
acid level (Carlson et al., 2005; Kari et al., 2008; Stephens et a l ,  1998; Thomson et al.,
2008). This is noteworthy considering C. trachomatis exists as 15 serovariants that elicit 
distinct disease pathology o f  either blinding trachoma (serovars A-C) or sexually 
transmitted infections that lead to upper genital tract disease (serovars D-K) or 
disseminate to the lymph nodes (serovars L1-L3; Schachter, 1978a; Schachter, 1978b, 
Schachter, 1978c). The human C. trachomatis strains and the murine pathogen, C. 
muridarum, share remarkable genomic synteny and more than 99% orthologous gene 
content (Read et al., 2000), but have distinct host and tissue tropisms. Comparative 
genomics analysis o f these two closely related strains revealed a hot spot o f genetic 
variability termed the PZ (Read et al., 2000). Studies suggest that strain- and species- 
specific alleles in the chlamydial PZ are critical to infection tropism and immune evasion 
strategies (Belland et al., 2001; Caldwell et al., 2003; Carlson et al., 2004; McClarty et 
al., 2007; Nelson et al., 2007; Nelson et al., 2005). A PZ encoded paralogous family o f 
putative phospholipase D (pzPLD) genes play an important role in chlamydial survival 
late in the developmental cycle (Nelson et a l ,  2006). CT153 is conserved among the 
sequenced C. trachomatis strains and lies immediately upstream from the pzPLDs 
suggesting these proteins share a concomitant role in chlamydia pathogenesis (Carlson et 
al., 2005; Ponting, 1999; Read et al., 2000; Stephens et al., 1998; Thomson et al., 2008).
The C-terminal half o f  C T 153 is strongly homologous to the membrane spanning 
region o f  the MACPF domain (Peitsch et al., 1990; Ponting, 1999; Rosado et al., 2007). 
MACPF domain-containing proteins from other pathogenic organisms function to 
destabilize host membranes (Ishino et al., 2005; Kadota et a l ,  2004; Kafsack et a l ,
2009). In Listeria monocytogenes, listeriolysin O and bacterial phospholipases mediate 
pathogen escape from the nascent membrane bound vacuole and disrupt host membranes 
during intercellular dissemination (Cossart et a l ,  1989; Smith et a l ,  1995). Thus, both 
the presence o f  a MACPF domain in CT153 and its linkage with the putative lipid 
modifying pzPLD proteins suggest the hypothesis that CT153 may interact with host cell 
membranes (Ponting, 1999).
Chapter tw o described a basic biological characterization o f  CT153 as an initial 
step in defining its role in chlam ydial pathogenesis. CT153 was expressed as a full 
length 91 kD a polypeptide in the EBs o f  15 hum an C. trachom atis serovars im plicating a 
com m on function. Results from im m unodot blots o f  EBs and neutralization o f  infectivity 
assays did not support CT153 involvem ent in host cell invasion and pointed tow ard a role 
for CT153 during intracellular growth. K inetic studies o f  C. trachom atis infected cells 
showed that CT153 was expressed at high levels during m id- through late-developm ental 
cycle, w hich is consistent w ith transcriptional analysis (Belland et al., 2003). CT153 was 
proteolytically processed to 59 kD a and 42 kD a polypeptides that associated prim arily 
w ith reticulate bodies (RBs) and insoluble cellular fractions of infected cells. 
Polypeptides o f  corresponding sizes w ere detected in eluates follow ing the purification of 
recom binant CT153 and were identified by  M A LD I-TO F m ass spectrom etry as a 42 kD a 
N -term inal fragm ent and a 59 kD a polypeptide that contains the C -term inal M ACPF 
dom ain. These findings suggest CT153 undergoes autocatalytic proteolysis that m ay be 
critical to the activity  o f  the protein and that processed form s o f  CT153 function in RBs 
m id- to late-developm ental cycle.
Confocal and im m unoelectron m icroscopy revealed that CT153 localized to a 
subpopulation o f  RBs intim ately associated w ith  the inner leaflet o f  the inclusion 
m em brane and to less abundant large atypical RBs in the inclusion lum en late in the 
developm ental cycle. Interestingly, the im m unoreactivity  detected for CT153 w as nearly  
indistinguishable from that o f  Hsp60. H sp60 localized to a distinct subset o f  m ature RBs 
positioned at the lum inal face o f  the inclusion and to the large RB developm ental forms. 
The differential staining o f  RBs we observed for CT153 and H sp60 was not an artifact o f 
fixation and perm eabilization because w e obtained identical results using different 
fixation conditions, and the sam e staining patterns for Hsp60 have been previously 
described (B annantine et al., 2000; B eatty et al., 1993; H euer et al., 2009). The staining 
patterns for CT153 and Hsp60 w ere strikingly sim ilar to w hat w e have recently described 
for the pzPLD , CT155 (Nelson et a l ,  2006), supporting a hypothesis that CT153 and the 
pzPLD s m ight be functionally related. Hsp60 is a chaperonin that ensures protein folding 
occurs w ith high fidelity  (E llis and van der V ies; 1991). These findings raise the 
intriguing possibility  that specialized developm ental form s populate m ature inclusions.
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W hat function could these “hyper” m etabolic RBs serve C. trachom atis late in the 
developm ental cycle? O rganism s that distribute the burden o f  acquiring m etabolic 
interm ediates to a subset o f  cells w ithin a population have a fitness advantage over a 
com peting species (K earns, 2008). C hlam ydiae are restricted to a m em brane bound 
vacuole term ed an inclusion that lim its access to the nutrient-rich host cell cytoplasm  
(H einzen and H ackstadt, 1997), but are dependent upon and m ust com pete w ith host cells 
for m etabolic interm ediates (M cClarty, 1999; M oulder, 1974). By m id-developm ental 
cycle the size o f  the inclusion expands and RBs enter logarithm ic growth. A s the 
pressure m ounts for Chlamydia  to access m ore host m etabolites, additional strategies m ay 
be deployed to ensure sufficient quantities o f  nutrients from host-derived sources. The 
chlam ydial inclusion intercepts G olgi-derived exocytic vesicles (H ackstadt et a l., 1996), 
fuses w ith m ultivesicular bodies (M V B) (Beatty, 2006) and sequesters lipid droplet (LD) 
organelles from  their host cells (Cocchiaro et al., 2008). These and other interactions 
result in the accum ulation o f  a variety  o f  host-derived lipids in C. trachom atis (H atch and 
M cClarty, 1998; W ylie et al., 1997). Listeria  and Rickettsia  express M A CPF dom ain 
containing proteins and phospholipases as virulence factors that m odify host m em branes 
(Cossart et al., 1989; Sm ith et al., 1995; W hitw orth et al., 2005). W e hypothesized that 
CT153 and the pzPLD s m ediated strain-specific transportation or m odification o f  
incom ing m em branes and lipids from  the host. W e first focused on chlam ydial 
interactions w ith M VBs. In vitro  M VB inhibition assays perform ed in cells infected w ith 
either C. trachom atis (CT153-positive) or C. caviae  (C T153-negative) indicated that 
norm al M VB m aturation was require for bo th  strains suggesting that M VB fusion is not 
unique to C. trachom atis and therefor m ost likely not m ediated by  CT153. This result 
suggested that CT153 functions in a specific interaction w ith host cells over a m ore 
generalized role in m em brane fusion events betw een Chlamydia  and the host.
Recent reports suggested at least two interactions w ith the host cell in w hich 
CT153 and the pzPLD s could potentially  function (Cocchiaro et al., 2008; H euer et al., 
2009). Chlamydia  acquires sphingolipids and cholesterol from  the Golgi w ithin the first 
4 h follow ing infection (Carabeo et al., 2003; Hackstadt et al., 1996). D uring logarithm ic 
grow th C. trachom atis induces Golgi fragm entation, w hich enhances the transport o f  
sphingolipids to the inclusion to support the increasing num bers o f  chlam ydial progeny
(Heuer et al., 2009). The kinetics o f CT153 expression and proteolytic processing 
coincides temporally with Chlamydia-induced Golgi fragmentation (Heuer et a l., 2009) 
and RBs expressing CT153, Hsp60 and a pzPLD (Nelson et al., 2006) were positioned on 
the inner leaflet o f the inclusion membrane. The fragmented Golgi ministacks cluster at 
the cytoplasmic face o f the inclusion membrane adjacent to Hsp60 expressing RBs 
(Heuer et al., 2009). The RBs expressing CT153, Hsp60 and a pzPLD would be 
optimally positioned at the inclusion membrane interface to intercept and process 
incoming Golgi-derived vesicles or lipids.
C. trachomatis inclusions initially interact transiently with LDs until the later 
stages o f  infection when more stable contacts are established and LDs are translocated to 
the lumen o f  mature inclusions and apparently consumed by RBs (Cocchiaro et al., 
2008). The differences between early and late chlamydial interaction with LDs could 
reflect an increase in chlamydial demand for host lipids. Interestingly, the kinetics of 
CT153 expression, proteolytic processing, and localization correlated temporally with the 
translocation o f LD from the cytosol into the chlamydial inclusion. To establish a link 
between CT153 and LDs, the distribution o f LDs between C. trachomatis (CT153- 
postive) and C. caviae (CT 153-negative) infected cells was compared using confocal 
microscopy. In contrast to C. trachomatis, C. caviae inclusions did not contain LDs, and 
this data argues that these strains interact with LDs differently. C. trachomatis inclusions 
contained prominent LDs inside and large RBs expressing CT153, Hsp60 and a pzPLD 
(Nelson et al., 2006) were immediately adjacent to an inclusion-sequestered LD. This is 
consistent with electron micrographs showing that incoming LDs establish tight 
interactions with RBs positioned on the inner leaflet o f  the inclusion membrane and are 
surrounded by membranous blebs and vesicles (Cocchiaro et al., 2008), which indicates 
active disruption or modification o f  the membranes. LDs are surrounded by a 
phosphatidylcholine-enriched phospholipid monolayer (Bartz et al., 2007) and the classic 
target o f PLDs is hydrolysis o f  the phosphodiester bond o f phosphatidylcholine. 
Furthermore, the pzPLD, CT156/Lda-1, localizes to LDs gathered at the cytoplasmic 
surface o f  the inclusion membrane (Kumar et al., 2006). W hile we were unable to 
biochemically establish a direct link between CT 153-positive RBs and intra-inclusion
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LDs in this study, w e present strong correlative data that points to a role for CT153 and 
the pzPLD s in the uptake and consum ption o f  lipids from  LDs.
Collectively, the findings presented here suggest that C. trachom atis CT153 plays 
a strain-specific role in the acquisition or m odification o f  host-derived lipids that is 
associated w ith a subpopulation o f  hyperm etabolic RBs. CT153 and the pzPLD s could 
represent virulence factors unique to C. trachom atis that are im portant to the 
pathogenesis o f  hum an infection and disease. This dissertation research has provided the 
first characterization o f  CT153 and should be useful as a prelim inary study for further 
investigation focused on defining its function in chlam ydial pathogenesis.
4.1.2 Future directions for CT153.
The w ork presented in this dissertation regarding CT153 opens up m any 
interesting questions that should be addressed in further studies. A w orking hypothesis 
for CT153 is this protein shares a concom itant function w ith the pzPLD s involving a C. 
trachom atis-specific aspect o f  acquisition or m odification o f  host-derived lipids from 
either Golgi derived vesicles or LDs. These studies provide evidence that CT153, Hsp60 
and one pzPLD , CT155, reside in a distinct subpopulation o f  RBs. To address the 
question i f  CT153 and the pzPLD s interact and thus perform  a shared function, Abs 
directed against CT153 and the pzPLD s generated in different species o f  anim als would 
allow  for im m uno-colocalization confocal and electron m icroscopy studies. These 
reagents could be em ployed to perform  a kinetic im m unoprecipitation study o f  CT153 
from infected cells to determ ine the binding partners o f  CT153. These experim ents 
w ould establish i f  CT153 interacts directly  w ith pzPLD s or other chlam ydial or 
eukaryotic proteins, including LD associated proteins. A  yeast tw o-hybrid screen could 
be utilized to confirm  CT153 interactions w ith other chlam ydial proteins, and also 
determ ine i f  CT153 form s hom otypic interactions. The pzPLD s contain an HK D m otif 
(Ponting and Kerr, 1996; Stephens et al., 1998) sim ilar to those seen in lipid m odifying 
enzym es, how ever definitive biochem ical studies are needed to confirm  the enzym ology 
and substrate specificity o f  these proteins. O ur data suggested that CT153 expressing 
RBs are in direct contact w ith LDs in m ature inclusions. It w ould be o f  interest to 
continue w ith ectopic expression o f  C T 153-fusion proteins in eukaryotic cells to
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determine if  the protein localizes to cytosolic LDs. Additionally, analysis ot purified 
LDs would indicate the association o f  CT153 with LD membranes. The kinetic 
immunoprecipitations o f  CT153 from infected cells would determine if CT153 interacts 
with LD associated proteins o f eukaryotic or chlamydial origin. Further studies 
elucidating the roles o f CT153 and the pzPLDs during infection are needed and will 
provide insights into whether these proteins function as other characterized PZ genes and 
contribute to Chlamydia's ability to establish persistent infection or evade the human 
immune response.
4.1.3 Polymorphic membrane protein D.
Gram-negative bacteria interact with host cells by translocating proteins to the 
bacterial cell surface or extracellular milieu (Finlay and Falkow, 1997). Secretion 
systems o f varying levels o f complexity have evolved to deliver virulence factors 
involved in initiating infection, disease progression and immune evasion (Gerlach and 
Hensel, 2007). The type V secretion system or autotransporter (AT) pathway is the most 
widespread and most highly efficient secretion pathway (Henderson et a l ,  2004). The 
chlamydial type V secretion proteins are termed polymorphic membrane proteins (Pmps) 
and are the most highly variable gene family o f  Chlamydiaceae (Henderson and Lam, 
2001; Kalman et a l , 1999; Read et al., 2000; Read et a l ,  2003; Stephens et a l,  1998). 
Considering that chlamydiae are fastidious organisms with a small genome and given the 
simplicity and efficiency o f the type V secretion pathway, it is not surprising that 
chlamydiae have duplicated and expanded this particular secretion mechanism. The 
functions o f  Pmps are largely undefined, but studies suggest they play an important role 
in chlamydial pathogenesis (Caldwell et a l,  1975a; Carlson et a l ,  2005; Crane et a l, 
2006; Kalman et a l,  1999; Knudsen et a l,  1991; Longbottom et a l ,  1996; Longbottom et 
a l,  1998a Longbottom et a l,  1998b; Mygind et a l,  2000; Stephens et a l,  1998).
C. trachomatis encodes nine pmp paralogs (pmpA-I) that are found at three 
chromosomal loci comprised o f two gene clusters (pmpA-C and pmpE-f) and the 
genetically isolated pmpD  (Stephens et a l,  1998). PmpD is highly conserved and 
expressed by all C. trachomatis serovars, is a major immunogen, and is the target o f 
broadly cross-reactive neutralizing Abs (Caldwell et a l,  1975b, Crane et a l ,  2006;
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Gomes et al., 2006). Thus, PmpD is an attractive vaccine candidate for the prevention of 
human infections. Proteolytic processing has been described for C. pneumoniae and C. 
trachomatis PmpD (Kiselev et al., 2007; Wehrl et al., 2004), and the C. pneumoniae 
ortholog has been suggested to function as an adhesin capable o f inducing pro- 
inflammatory cytokines (Niessner et al., 2003; Wehrl et al. 2004). The potential for 
PmpD as a vaccine candidate antigen and important virulence factor prompted us to gain 
a better understanding o f the structure and function o f  the native protein. Chapter three 
describes the native structure o f C. trachomatis PmpD and shows that the protein 
undergoes multiple proteolytic processing steps to produce a two distinct forms and 
provides insights into the function o f PmpD during infection.
Type V secretion proteins are characterized a common configuration o f  three 
domains: (i) a signal sequence, (ii) a diverse N-terminal passenger domain (PD) that 
confers effector function, and (iii) a conserved C-terminal translocator domain (TD). The 
TD inserts into the outer membrane by assembling into a p-barrel pore that facilitates PD 
translocation to the bacterial surface. The PD remains tethered to the TD or is cleaved 
and either released or remains non-covalently associated with the outer membrane 
(Dautin and Bernstein, 2007; Henderson et al., 2004). PmpD shares many characteristics 
found in ATs including a relatively large size (1530 aa, 160.5 kDa), N-terminal 
GGA[I/L/V] and FXXN tetrapeptide repeats (Grimwood and Stephens, 1999), an 
integrin-binding RGD m otif (aa 698-670) (Takada et al., 2007), and a putative bipartite 
nuclear localization signal (NLS; aa 783-798) (Boulikas, 1993). In agreement with a type 
V secretion model o f  processing, western blots o f  EBs using Abs directed against the N- 
terminal, middle and C-terminal regions o f  PmpD showed the protein was proteolytically 
processed into a 73 kDa N-terminal PD and an 82 kDa C-terminal TD, consistent with 
previous reports (Kiselev et al., 2007; Wehrl et al. 2004). Importantly, the proteolytic 
cleavage sites o f  the mature protein were identified at V53 and L762. It is unclear at this 
time if  the processing o f  PmpD occurs by an autocatalytic mechanism or by a separate 
chlamydial or host protease.
PmpD was purified by immunoaffinity chromatography and the eluted protein 
was further analyzed to gather information regarding the native structure. PmpD was 
unique compared to other Pmps (Tanzer et al., 2001) in that it was efficiently extracted
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from EBs using the non-ionic detergent octyl p-D-glucopyranoside. The significance of 
this finding is not clear. ATs found on the bacterial cell surface can function as 
monomers or oligomer (Lupetti, et al., 1996; Oomen et a l ,  2004). Two-dimension blue 
native/SDS-PAGE (Wittig et al., 2006) followed by W estern blotting revealed that native 
PmpD exists on the chlamydial surface as a higher-order oligomer composed o f the 
mature frill length p i 55, p73 PD and p82 TD. The oligomers exhibited a -23  nm ring 
surrounded by 5-6 symmetrically arrayed petals to form a flower-like structure. Similar 
to other ATs that function as virulence factors (Dautin and Bernstein, 2007), PmpD 
oligomers were polarized on the outer surface o f EBs. This clustering is suggestive o f  the 
asymmetric hemispheric projections described on the surface o f  both C. psittaci and C. 
trachomatis EBs (Gregory et al., 1979; Matsumoto, 1982a). In contrast to EBs, PmpD 
oligomers were more homogeneously distributed and more abundant on purified RBs. 
The biochemical characteristics o f  immunoaffinity purified PmpD including i) oligomer 
size, ii) flower-like structure, iii) abundance on RBs, and iv) asymmetric localization on 
EBs are strikingly similar to the features o f the rosette structures described following 
freeze-deep etching o f  chlamydial organisms (Matsumoto, 1982b). The rosettes are 
thought to provide the base in the outer membrane through which the surface projections 
extend from the center (Matsumoto, 1988). These complexes described by Matsumoto 
and others (Chang et a l ,  1982; Gregory et al., 1979; Matsumoto, 1982b Matsumoto, 
1988; Soloff et al., 1982) are speculated to be subunits o f the chlamydial type III 
secretion apparatus (Bavoil and Hsia, 1998). Our data do not exclude the possibility that 
other proteins could form similar structures. However, the strong immunochemical and 
biochemical evidence presented in this dissertation suggests the previously described 
surface structures are PmpD oligomers. The other eight C. trachomatis type V secretion 
family members are all expressed during infection (Grimwood et al., 2001; Nunes et al., 
2007) and could form similar structures. It is not clear whether these Pmps exist as 
higher-ordered structures or if  they interact with PmpD in the outer membrane.
We also analyzed the intracellular localization o f  PmpD during the developmental 
cycle by confocal microscopy. As expected from the aforementioned studies, the TD 
portion o f protein associated strongly with the outer membrane. The N-terminal PD and 
middle region o f PmpD were localized to the outer membrane, but also exhibited intra-
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inclusion staining that was diffuse or intensely fluorescent punctate clusters. These 
findings suggested that Pm pD existed as m ultiple structures in infected cells including 
organism  associated and soluble form s generated by  possible secondary cleavage events. 
Cellular fractionation experim ents validated the organism  associated form s o f  PmpD. 
Im portantly, these experim ents show ed that PmpD underw ent an infection-dependent 
proteolytic processing step late in the growth cycle that yielded a soluble extended PD 
( p i l l )  that was further processed into a p73 PD and a novel C-term inal p30 fragm ent. It 
is notew orthy that this cleavage segregated the RGD and NLS eukaryotic interacting 
m otifs to the p73 and the p30, respectively. T hese findings indicated that the soluble 
forms Pm pD are not structural, but are possible effectors that function during the later 
stages o f  infection by engaging eukaryotic targets.
The w ork presented here show s Pm pD exists as tw o separate forms: a surface 
associated oligom er exhibiting a higher-ordered flow er-like structure and soluble forms 
that contain eukaryotic interacting m otifs. The rem arkable sim ilarities o f  these form s o f  
Pm pD to other ATs such as H. p y lo ri VacA (Torres et al., 2005) and the N eisseria  IgA 
protease (Pohlner et a l ., 1995) suggests Pm pD is proteolytically  processed to generate 
distinct functional subunits and prom pted us to develop the w orking m odel presented in 
chapter three. In this m odel we proposed at least two distinct functions for Pm pD at 
different stages o f  the chlam ydial developm ental cycle. T he Pm pD oligom ers polarized 
on the EB surface likely function in early  host cell interactions, and this is supported by 
previous studies show ing that anti-Pm pD  Abs block infectivity (Crane et al., 2006; W ehrl 
et al., 2004). The late infection-dependent soluble form s o f  Pm pD  m ay be secreted 
effector proteins that access the cytosol o f  the infected cell. A lternatively, Pm pD m ight 
be released follow ing inclusion extrusion or host cell lysis (H ybiske and Stephens, 2007; 
Todd and Caldwell, 1985) into the local environm ent to interact w ith cellular targets at 
the site o f  infection. Late C. trachom atis infections induce apoptosis in neighboring 
uninfected epithelial cells through an unknow n m echanism  (Schoier et al., 2001). 
Interestingly, H. py lori VacA oligom ers have T  cell suppressive activity (G ebert et al., 
2003), and chlam ydial infections suppress the developm ent o f  m em ory CD8^ T cells 
(Loom is and S tam bach, 2006). It will be o f  particular interest to determ ine i f  the 
m olecular m echanism s for either o f  these pathogenic activities are m ediated by PmpD.
94
Taken together, the findings presented here suggest Pm pD is a m ultifunctional 
virulence factor im portant in chlam ydial pathogenesis. The results also have significant 
im plications for the design o f  a Pm pD -based chlam ydial vaccine. Further studies 
elucidating the structure and function o f  the m ultiple PmpD form s will be instrum ental in 
this endeavour and are discussed below.
4.1.4 Future directions for PmpD.
T o build upon the studies presented in chapter 3 in silico  structural studies were 
perform ed to gain insight into the native structure o f  PmpD. D raw ing on crystal 
structures o f  w ell-characterized type V proteins, structural m odels w ere developed o f  a 
predicted {3-helix region (aa 574-944) and the C-term inal [3-domain (aa 1222-1530). The 
C-term inal region o f  PmpD is predicted to form  a 12-stranded (3-barrel sim ilar to the 13- 
dom ain o f  N eisseria m eningitidis NalP (O om en et al., 2004) suggesting PmpD 
oligom erizes after translocation o f  the passenger dom ain (PD) to the chlam ydial surface. 
C om parative structural analysis o f  the C-term inal regions o f  all nine Pmps from  C. 
trachom atis indicates they are type V a ATs. The N -term inal soluble p i l l  extended PD 
contains a region from  aa 574-944 predicted to form  a right-handed parallel [3-helix. The 
tight turns o f  the [3-helix are facilitated by  the G GA [I/LV] repeats in the N -term inal h a lf 
o f  the protein. This repeat defines the Pm p fam ily; therefore our data suggest other Pmp 
passenger dom ains fold into sim ilar structures. T he m odels generated in this analysis 
indicate that the RGD integrin-binding m o tif and putative NLS protrude from  loops 
w ithin the [3-helix scaffold presum ably to interact w ith host targets. The proteolytic 
processing site at L762 is protected w ithin the structure o f  the [3-helix im plying that 
PmpD processing is C hlam ydia-specific and autocatalytic. Exposed functional m otifs 
adjacent to either side o f  the proteolytic cleavage site support our hypothesis that PmpD 
is a m ultifunctional virulence factor. T hese data yield im portant insights into the 
structure o f  Pm pD and provide a basis for m ore detailed characterization o f  PmpD 
function.
Future studies for PmpD w ould look to our m odel o f  Pm pD  structure and function 
as a w orking hypothesis and serve as a fram e w ork for guiding studies focused on 
elucidating role o f  the m em brane associated oligom ers and soluble form s o f  PmpD
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during chlam ydial pathogenesis. Our w orking m odel o f  PmpD hypothesizes that late 
soluble forms o f  PmpD are secreted into small quantities into the cytosol or released at 
the end o f  the developm ental cycle w hen the cell lyses or the inclusion egresses. Cellular 
fractionations using perfringolysin O in w hich the cytosolic fraction o f  infected cells is 
selectively isolated (K leba and Stephens, 2008) w ould establish i f  Pm pD  is secreted into 
the host cell cytosol during the late stages o f  infection. A kinetic study analyzing 
infected cell culture supernatants by  W estern blotting  w ould determ ine i f  Pm pD is 
released at the end o f  the infectious cycle. One o f  the m ost interesting aspects o f  PmpD 
is the late soluble form s that are produced late during infection that contain putative 
eukaryotic interacting m otifs. PmpD is proteolytically processed to a p73 that contains 
an RGD m o tif and a p30 w ith putative NLS. It will be im portant to precisely define the 
sites o f  proteolytic cleavage that generate these polypeptides and use this inform ation to 
guide further experim ents aim ed at determ ining the function o f  the eukaryotic interacting 
m otifs. For exam ple, in vitro assays using recom binant and m utated p73 will define a 
role for the RGD m o tif in host cell interactions and p30 fusion proteins can be ectopically 
expressed in eukaryotic cells to determ ine i f  the NLS is functional. I f  the p30 localizes to 
the nucleus it w ill be o f  utm ost im portance to identify p30 nuclear targets and determ ine 
i f  there is an effect on host gene expression. The question rem ains i f  the processed forms 
rem ain stably associated or i f  they exist separately. 2D BN /SD S-PA G E gels o f  soluble 
fractions w ould determ ine i f  soluble Pm pD  polypeptides form  a higher-ordered structure. 
The native structure we have defined in this study for Pm pD is strongly supported b y  the 
bioinform atics prediction o f  an extended (3-helix in the PD, and this structure is strikingly 
sim ilar to H. py lori VacA. V ac A oligom ers have T  cell suppressive activity (G ebert et 
al., 2003), and it will critical to determ ine i f  Pm pD has a sim ilar function. This can be 
tested in vivo  by  infecting m ice w ith a m odified vaccinia virus expressing different form s 
o f  Pm pD and analyzing the effects on T  cell populations. A  better understanding o f  
PmpD structure will be fundam ental to elucidating its role in chlam ydial pathogenesis 
and will be crucial in the design o f  a Pm pD -based vaccine capable o f  inducing 
neutralizing antibodies against a spectrum  o f  Pm pD -m ediated activities.
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